Compound

L-valine

A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.

Definition from MeSH (D014633), National Library of Medicine, read 2026-09-23. NLM revises MeSH; this copy may not reflect its current record.

CHEBI:16414ChEBI

Open in the graph

Studied for

1 endpoint · 1 finding · 1 paper

HDAC6raisesEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.

Every finding, with the quotes

Structure

The L-enantiomer of valine.

2D depiction · 3D model shown

Loading the model…

A generated conformer of L-valine — one low-energy arrangement PubChem computed, not a measured structure. Hydrogens are not drawn; the formula counts them.

Class: Organic compound
Formula: C5H11NO2
Mass: 117.148 g/mol
Charge: 0
InChIKey: KZSNJWFQEVHDMF-BYPYZUCNSA-N
SMILES: CC(C)[C@H](N)C(=O)O
Look it up: ChEBI PubChem By InChIKey

Identity from ChEBI, geometry from PubChem. Not evidence.

What the evidence says

How to read these marks

1 finding · 1 endpoint · 1 paper · by evidence strength

Heavier lines are better evidence, and a line with a gap in the middle is an inference rather than a reported result. Two lines arriving at one endpoint are two findings of it, marked ×2. How evidence strength is computed.

What moved

1 finding

Binds HDAC6
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding
“Here we identify that human histone deacetylase 6 (HDAC6) serves as a valine sensor by directly binding valine through a primate-specific SE14 repeat domain.”
Quoted verbatim from Human HDAC6 senses valine abundancy to regulate DNA damage..
Study

in vitro · not in humans
Population

human HDAC6 protein (exact binding-assay system not specified in the abstract)
Human HDAC6 senses valine abundancy to regulate DNA damage.2025PMID:39567688Permalink

What it touches on the way

Mechanistic reach

19 entities

19 entities reached.

0 reported hops19 assembled from the scaffold

Show the remaining 7

What the reference databases state

Statements

84 statements

84 statements · 2 reference databases · Subject: L-valine · Sources: Human-GEM, Rhea

Order

L-valine is converted to 3-methyl-2-oxobutanoateCompoundHuman-GEM MAR03744Inferred only
3-methyl-2-oxobutanoate is converted to L-valineCompoundRhea RHEA:11156Inferred only
L-valine is converted to 3-methyl-2-oxobutanoateCompoundHuman-GEM MAR03747Inferred only
3-methyl-2-oxobutanoate is converted to L-valineCompoundRhea RHEA:30763Inferred only
3-methyl-2-oxobutanoate is converted to L-valineCompoundRhea RHEA:61252Inferred only
L-valine is converted to 3-methyl-2-oxobutanoateCompoundRhea RHEA:11156Inferred only
L-valine is converted to 3-methyl-2-oxobutanoateCompoundRhea RHEA:30763Inferred only
L-valine is converted to 3-methyl-2-oxobutanoateCompoundRhea RHEA:61252Inferred only
L-valine is converted to 3-methyl-2-oxobutanoateCompoundRhea RHEA:24813Inferred only
L-valine is a substrate of BCAT1ProteinRhea RHEA:24813Inferred only
L-valine is a substrate of BCAT1ProteinHuman-GEM MAR03747Inferred only
L-valine is a substrate of BCAT2ProteinHuman-GEM MAR03744Inferred only

Show the remaining 72

L-valine is a substrate of BCAT2ProteinRhea RHEA:24813Inferred only
L-valine is a substrate of VARS1ProteinHuman-GEM MAR05150Inferred only
L-valine is a substrate of VARS1ProteinRhea RHEA:10704Inferred only
L-valine is a substrate of VARS2ProteinRhea RHEA:10704Inferred only
L-valine is transported by CLTRNProteinHuman-GEM MAR09909Inferred only
L-valine is transported by SLC1A5ProteinRhea RHEA:70871Inferred only
L-valine is transported by SLC25A44ProteinRhea RHEA:29703Inferred only
L-valine is transported by SLC36A1ProteinHuman-GEM MAR05063Inferred only
L-valine is transported by SLC36A1ProteinHuman-GEM MAR05089Inferred only
L-valine is transported by SLC3A1ProteinHuman-GEM MAR05935Inferred only
L-valine is transported by SLC3A1ProteinHuman-GEM MAR05951Inferred only
L-valine is transported by SLC3A1ProteinHuman-GEM MAR05967Inferred only
L-valine is transported by SLC3A1ProteinHuman-GEM MAR05983Inferred only
L-valine is transported by SLC3A1ProteinHuman-GEM MAR05919Inferred only
L-valine is transported by SLC3A2ProteinHuman-GEM MAR05089Inferred only
L-valine is transported by SLC43A1ProteinRhea RHEA:29703Inferred only
L-valine is transported by SLC43A1ProteinHuman-GEM MAR05089Inferred only
L-valine is transported by SLC43A2ProteinHuman-GEM MAR05089Inferred only
L-valine is transported by SLC6A14ProteinRhea RHEA:71307Inferred only
L-valine is transported by SLC6A14ProteinHuman-GEM MAR09598Inferred only
L-valine is transported by SLC6A15ProteinRhea RHEA:29267Inferred only
L-valine is transported by SLC6A15ProteinHuman-GEM MAR05314Inferred only
L-valine is transported by SLC6A18ProteinHuman-GEM MAR09909Inferred only
L-valine is transported by SLC6A19ProteinHuman-GEM MAR05314Inferred only
L-valine is transported by SLC6A19ProteinRhea RHEA:29267Inferred only
L-valine is transported by SLC7A10ProteinRhea RHEA:74047Inferred only
L-valine is transported by SLC7A13ProteinRhea RHEA:76323Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05546Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05559Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05564Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05568Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05572Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05573Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05574Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05496Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05628Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05643Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05658Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05673Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05483Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05469Inferred only
L-valine is transported by SLC7A5ProteinRhea RHEA:29703Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05553Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05089Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05598Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05508Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05519Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05529Inferred only
L-valine is transported by SLC7A5ProteinHuman-GEM MAR05538Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05888Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05598Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05628Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05767Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05768Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05776Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05781Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05887Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05889Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05890Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05919Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05935Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05951Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05967Inferred only
L-valine is transported by SLC7A6ProteinHuman-GEM MAR05983Inferred only
L-valine is transported by SLC7A7ProteinHuman-GEM MAR05089Inferred only
L-valine is transported by SLC7A8ProteinRhea RHEA:71019Inferred only
L-valine is transported by SLC7A8ProteinHuman-GEM MAR05089Inferred only
L-valine is transported by SLC7A9ProteinHuman-GEM MAR05983Inferred only
L-valine is transported by SLC7A9ProteinHuman-GEM MAR05967Inferred only
L-valine is transported by SLC7A9ProteinHuman-GEM MAR05951Inferred only
L-valine is transported by SLC7A9ProteinHuman-GEM MAR05935Inferred only
L-valine is transported by SLC7A9ProteinHuman-GEM MAR05919Inferred only

Reactions

154 reactions

L-alanine+L-arginine+L-asparagine+L-aspartate+CHEBI:1307929+a cholesterol ester+a cardiolipin+MAM01602c+L-cysteine+MAM01721n+MAM01722n+L-glutamate(1-)+L-glutamine+glycine+CHEBI:15971+L-isoleucine+L-leucine+MAM02392c+CHEBI:18019+L-methionine+L-phenylalanine+phosphatidic acid+1-phosphatidyl-1D-myo-inositol+CHEBI:17203+MAM02847c+L-seryl residue+a sphingomyelin+CHEBI:16857+L-tryptophan+CHEBI:17895+L-valine+MAM03161cMAM03970c
Reaction pageBlockedBalance undeterminablecytosol, endoplasmic reticulum, nucleus
Human-GEM MAR00021CC BY 4.0Reference data
L-valineL-valine
Reaction pageReversibleBalancedcytosol, mitochondrial matrix
Human-GEM MAR01821CC BY 4.0Reference data
2-oxoglutarate(2-)+L-valine3-methyl-2-oxobutanoate+L-glutamate(1-)
Catalysed by BCAT2
Reaction pageLeft to rightBalancedEC 2.6.1.42mitochondrial matrix
Human-GEM MAR03744CC BY 4.0Reference data
2-oxoglutarate(2-)+L-valine3-methyl-2-oxobutanoate+L-glutamate(1-)
Catalysed by BCAT1
Reaction pageLeft to rightBalancedEC 2.6.1.42cytosol
Human-GEM MAR03747CC BY 4.0Reference data
0.505626L-alanine+0.35926L-arginine+0.279425L-asparagine+0.352607L-aspartate+20.704451ATP+0.020401CHEBI:1307929+0.011658a cardiolipin+0.039036CHEBI:17677+0.046571L-cysteine+0.013183CHEBI:16284+0.009442dCTP+0.009898CHEBI:16497+0.013091dTTP+0.275194D-glucopyranose 6-phosphate+0.385872L-glutamate(1-)+0.325996L-glutamine+0.538891glycine+0.036117GTP+20.650823water+0.126406CHEBI:15971+0.286078L-isoleucine+0.545544L-leucine+0.592114CHEBI:18019+0.153018L-methionine+0.1544631,2-diacyl-sn-glycero-3-phosphocholine(1+)+0.055374phosphatidylethanolamine+0.002914MAM02715c+0.259466L-phenylalanine+0.0233151-phosphatidyl-1D-myo-inositol+0.412484CHEBI:17203+0.005829phosphatidyl-L-serine+0.392525L-seryl residue+0.017486a sphingomyelin+0.31269CHEBI:16857+0.013306L-tryptophan+0.159671CHEBI:17895+0.053446UTP+0.352607L-valine20.650823ADP+20.650823proton+20.650823phosphate(3-)+MAM03970c
Reaction pageBlockedBalance undeterminablecytosol, nucleus
Human-GEM MAR04413CC BY 4.0Reference data
L-valineL-valine
Transported by SLC36A1
Reaction pageLeft to rightBalancedlysosome, cytosol
Human-GEM MAR05063CC BY 4.0Reference data
L-valineL-valine
Transported by SLC3A2 & SLC7A8 or SLC7A5 or SLC36A1 or SLC43A1 or SLC7A7 or SLC43A2
Reaction pageReversibleBalancedcytosol, extracellular space
Human-GEM MAR05089CC BY 4.0Reference data
proton+L-valineproton+L-valine
Reaction pageLeft to rightBalancedmitochondrial intermembrane space, cytosol, mitochondrial matrix
Human-GEM MAR05118CC BY 4.0Reference data
ATP+MAM03082c+L-valineAMP+MAM02423c+diphosphate(3-)
Catalysed by VARS1
Reaction pageLeft to rightBalance undeterminableEC 6.1.1.9cytosol
Human-GEM MAR05150CC BY 4.0Reference data
MAM01308c+608ATP+1216water608ADP+63L-alanine+27L-arginine+17L-asparagine+36L-aspartate+35L-cysteine+62L-glutamate(1-)+20L-glutamine+13glycine+619proton+16CHEBI:15971+9L-isoleucine+64L-leucine+60CHEBI:18019+7L-methionine+35L-phenylalanine+608phosphate(3-)+24CHEBI:17203+28L-seryl residue+29CHEBI:16857+2L-tryptophan+19CHEBI:17895+43L-valine
Catalysed by ALB
Reaction pageLeft to rightBalancedcytosol
Human-GEM MAR05258CC BY 4.0Reference data
MAM01308l+608ATP+1216water608ADP+63L-alanine+27L-arginine+17L-asparagine+36L-aspartate+35L-cysteine+62L-glutamate(1-)+20L-glutamine+13glycine+619proton+16CHEBI:15971+9L-isoleucine+64L-leucine+60CHEBI:18019+7L-methionine+35L-phenylalanine+608phosphate(3-)+24CHEBI:17203+28L-seryl residue+29CHEBI:16857+2L-tryptophan+19CHEBI:17895+43L-valine
Catalysed by CTSA or CTSG or LGMN or CTSZ or CTSH or CTSC or CTSD or CTSL or CTSV or CTSK or CTSS or CTSB and 5 more alternatives
Reaction pageLeft to rightBalancedlysosome
Human-GEM MAR05259CC BY 4.0Reference data
MAM01343c+422ATP+844water422ADP+34L-alanine+16L-arginine+19L-asparagine+25L-aspartate+3L-cysteine+29L-glutamate(1-)+17L-glutamine+16glycine+434proton+9CHEBI:15971+20L-isoleucine+59L-leucine+26CHEBI:18019+14L-methionine+25L-phenylalanine+422phosphate(3-)+16CHEBI:17203+30L-seryl residue+29CHEBI:16857+3L-tryptophan+9CHEBI:17895+24L-valine
Reaction pageLeft to rightBalancedcytosol
Human-GEM MAR05260CC BY 4.0Reference data

Show the remaining 142

On the label

Labelled products

763 products

Source: NIH DSLD · Ingredient: L-valine · 763 products · Declared amount per serving: 2.86–3,519 mg (564 products)

745 labels state an amount18 do not

Order

1 Up NutritionBCAA's Glutamine & Collagen Candy Watermelon1,000 mgper 15 Gram(s)DSLD:64636
1 Up NutritionBCAA's Glutamine & Collagen Pineapple1,000 mgper 15 Gram(s)DSLD:64634
1 Up NutritionBCAA's Glutamine & Collagen Raspberry Lemonade1,000 mgper 15 Gram(s)DSLD:64635
1 Up NutritionBCAA's Glutamine & L-Carnitine Candy Watermelon1,600 mgper 15 Gram(s)DSLD:64714
1 Up NutritionBCAA's Glutamine & L-Carnitine Pineapple1,600 mgper 15 Gram(s)DSLD:64637
1 Up NutritionBCAA's Glutamine & L-Carnitine Raspberry Lemonade1,600 mgper 15 Gram(s)DSLD:64638
1st PhormAnabolic Bridge692 mgper 8 Capsule(s)DSLD:242704
1st PhormBCAA Apple Juice2,000 mgper 11 Gram(s)DSLD:242705
1st PhormBCAA Blue Raspberry2,000 mgper 11 Gram(s)DSLD:242713
1st PhormBCAA Green Apple2,000 mgper 11 Gram(s)DSLD:242719
1st PhormBCAA Lemonade2,000 mgper 11 Gram(s)DSLD:242722
1st PhormBCAA Pineapple Mango2,000 mgper 11.3 Gram(s)DSLD:242723

Show the remaining 751

1st PhormIntra-Formance Lemon Lime1,000 mgper 31.8 Gram(s)DSLD:242858
1st PhormIntra-Formance Orange1,000 mgper 31.8 Gram(s)DSLD:242859
21st CenturyDaily Amino Acid58 mgper 1 Tablet(s)DSLD:258438
6AM RunFinishLine Lemon Lime1,000 mgper 6.5 Gram(s)DSLD:337316
6AM RunFinishLine Watermelon1,000 mgper 6.5 Gram(s)DSLD:337317
Absorb HealthBCAA 2:1:1375 mgper 1.5 Gram(s)DSLD:215652
AdvocareCatalyst225 mgper 3 Capsule(s)DSLD:60518
AdvoCareBioCharge500 mgper 4.35 Gram(s)DSLD:206881
AdvoCareBioCharge Peach & Mixed Berry500 mgper 1 Stick Pack(s)DSLD:318407
AdvoCareCatalyst225 mgper 3 Capsule(s)DSLD:265036
AdvoCarePost-Workout Recovery Chocolate 100 mgper 2 Ounce(s)DSLD:296897
AdvoCarePost-Workout Recovery Vanilla100 mgper 60 Gram(s)DSLD:296898
AjinomotoFusi-BCAA Fruit Punch Flavor1,250 mgper 8.83 Gram(s)DSLD:81433
AjinomotoFusi-BCAA Lemon Flavor1,250 mgper 8.31 Gram(s)DSLD:81437
AjinomotoFusi-BCAA Pure & Unflavored1.25 Gram(s)per 5 Gram(s)DSLD:81375
AjinomotoFusi-BCAA Pure & Unflavored1.25 Gram(s)per 5 Gram(s)DSLD:81409
Alani NuBCAA BerryVegan InstAminos1.25 Gram(s)per 7.9 Gram(s)DSLD:247871
Allergy Research GroupAmino Acid Neurotransmitter Formula74 mgper 4 Gram(s)DSLD:54247
Allergy Research GroupTake Heart II Without Hormones40 mgper 20 Gram(s)DSLD:54484
Allergy Research GroupTake Heart II Without Hormones40 mgper 20 Gram(s)DSLD:54477
Amazing MusclePre Rise Fruit Punch1 Gram(s)per 21 Gram(s)DSLD:251083
American MetabolixWarpath Fruit Punch250 mgper 1 Scoop(s)DSLD:199563
ANSI Pro-SeriesBCAA 1000L-Valine Note: (usp) (Free Form)100 mgper 2 Capsule(s)DSLD:21003
ANSI Pro-SeriesBCAA 2200L-Valine Note: (usp) (Free Form)220 mgper 4 Capsule(s)DSLD:21005
ANSI Pro-SeriesInstantized BCAA 12400 Blue RaspberryL-Valine Note: (usp) (Free Form)620 mgper 11.5 Gram(s)DSLD:21008
ANSI Pro-SeriesInstantized BCAA 12400 Fruit PunchL-Valine Note: (usp) (Free Form)620 mgper 11.5 Gram(s)DSLD:21010
ANSI Pro-SeriesInstantized BCAA 12400 GrapeL-Valine Note: (usp) (Free Form)620 mgper 11.5 Gram(s)DSLD:21012
ANSI Pro-SeriesInstantized BCAA 12400 WatermelonL-Valine Note: (usp) (Free Form)620 mgper 11.5 Gram(s)DSLD:21013
Apollon NutritionChainsaw Blue Bomb1,250 mgper 12 Gram(s)DSLD:215752
Apollon NutritionEnigma Passion Fruit1,200 mgper 21.6 Gram(s)DSLD:215758
Apollon NutritionEnigma Pineapple1,200 mgper 22 Gram(s)DSLD:235587
Approved ScienceBCAA 2:1:1 +BioPerine600 mgper 1 Tablet(s)DSLD:319724
ATP ScienceVegan Essential Aminos Cola750 mgper 6 Gram(s)DSLD:241753
ATP ScienceVegan Essential Aminos Raspberry750 mgper 6 Gram(s)DSLD:241760
BELDT LabsRebaar780 mgper 3 Tablet(s)DSLD:237023
BELDT LabsRebaar750 mgper 3 Tablet(s)DSLD:331479
Best NaturalsBCAA 3200 mg800 mgper 4 Capsule(s)DSLD:269289
Best NaturalsBCAA 3200 mg800 mgper 4 Capsule(s)DSLD:270350
Best NaturalsBCAA Pure PowderFree-Form1,300 mgper 5.2 Gram(s)DSLD:269247
Beverly InternationalDensity500 mgper 5 Tablet(s)DSLD:332818
Beverly InternationalGlutamine Select Black Cherry750 mgper 9.2 Gram(s)DSLD:332832
Beverly InternationalGlutamine Select Wild Berry750 mgper 9.4 Gram(s)DSLD:332833
Beverly InternationalMuscle Mass1,000 mgper 5 Tablet(s)DSLD:332837
Beverly InternationalMuscularity835 mgper 2 Capsule(s)DSLD:332851
BiochemH Hydro Recovery Coconut FlavorVegan L-Valine250 mgper 4.9 Gram(s)DSLD:183896
BiolayneCarbon Recover Blueberry Pomegranate2 Gram(s)per 14.9 Gram(s)DSLD:202622
BiolayneCarbon Recover Sour Apple2 Gram(s)per 15.65 Gram(s)DSLD:202625
BiosteelAdvanced Recovery Formula Vanilla1,436 mgper 36 Gram(s)DSLD:30899
BioSteelAdvanced Recovery Formula Chocolate1,436 mgper 36 Gram(s)DSLD:30953
BioSteelBioSteel Hydration Mix Mixed Berry Flavor544 mgper 7 Gram(s)DSLD:273699
BioSteelBioSteel Hydration Mix Rainbow Twist Flavor544 mgper 7 Gram(s)DSLD:273703
BioSteelBioSteel Hydration Mix White Freeze Flavor544 mgper 7 Gram(s)DSLD:271048
BioSteelBioSteel Sports Hydration Mix Blue Raspberry536 mgper 0.24 ozDSLD:273737
BioSteelBioSteel Sports Hydration Mix Lemon-Lime536 mgper 0.24 ozDSLD:273736
BioSteelBioSteel Sports Hydration Mix Mixed Berry536 mgper 0.24 ozDSLD:271055
BioSteelBioSteel Sports Hydration Mix Orange536 mgper 0.24 ozDSLD:273726
BioSteelBioSteel Sports Hydration Mixed Berry536 mgper 0.24 ozDSLD:273727
BioSteelWhey Protein Isolate Chocolate1,374 mgper 32 Gram(s)DSLD:30990
BioSteelWhey Protein Isolate Vanilla1,374 mgper 32 Gram(s)DSLD:30993
Biotics Research CorporationAmino Sport79 mgper 3 Capsule(s)DSLD:21470
BioTrustBCAA Matrix75 mgper 4 Veggie Capsule(s)DSLD:64579
BIOVEABCAA1,600 mgper 8 Vegetarian Capsule(s)DSLD:248957
BIOVEABCAA250 mgper 2 Capsule(s)DSLD:45523
BIOVEA Natural FoodsSilk Brown Rice Protein1,440 mgper 4 TbspDSLD:65970
Blackstone LabsBCAA Resurgence Kiwi Strawberry1.25 Gram(s)per 7 Gram(s)DSLD:219494
Blackstone LabsBCAA Resurgence Orange1.25 Gram(s)per 7 Gram(s)DSLD:219524
Blackstone LabsBCAA Resurgence Pina Colada1 Gram(s)per 11 Gram(s)DSLD:204827
Body AttackBCAA 6000 mg + L-Glutamine 6000 mg1,500 mgper 5 Capsule(s)DSLD:329538
Body AttackExtreme Instant EAA Blackberry FlavourBranched chain amino acid1,229 mgper 14 Gram(s)DSLD:329555
Body AttackExtreme Instant EAA Cherry FlavourBranched chain amino acid1,229 mgper 14 Gram(s)DSLD:334227
Body AttackExtreme Instant EAA Ice Tea Lemon FlavourBranched chain amino acid1,229 mgper 14 Gram(s)DSLD:334229
Body AttackExtreme Instant EAA Watermelon FlavourBranched chain amino acid1,229 mgper 14 Gram(s)DSLD:334233
Body Attack Sports Nutrition100% Whey Protein ApfelstrudelBCAA, Amino Acid Profile5.64 Gram(s)per 30 Gram(s)DSLD:329523
Body Attack Sports NutritionExtreme Instant BCAA Mojito Flavour2,500 mgper 13 Gram(s)DSLD:335171
Body Attack Sports NutritionPower Protein 90 Apricot-Maracuya Flavouradded substances0.15 Gram(s)per 30 Gram(s)DSLD:337737
Body Attack Sports NutritionPower Protein 90 Banana Flavouradded substances0.15 Gram(s)per 30 Gram(s)DSLD:337738
Body Attack Sports NutritionPower Protein 90 Blueberry-Yoghurt Creamadded substances0.25 Gram(s)per 30 Gram(s)DSLD:334252
Body Attack Sports NutritionPower Protein 90 Coconut Creamadded substances0.15 Gram(s)per 30 Gram(s)DSLD:334253
Body FortressBCAA 2200500 mgper 4 Softgel(s)DSLD:19307
Body FortressBCAA Tri-Amino Complex250 mgper 2 Softgel(s)DSLD:21343
Body KitchenHydrolyzed Protein Collagen Decadent Chocolate0.49 Gram(s)per 22 Gram(s)DSLD:241118
Bodybuilding.com Foundation SeriesBCAA Powder1.25 Gram(s)per 5 Gram(s)DSLD:199880
Bodybuilding.com Platinum SeriesAMP'D Recovery Blue Raspberry750 mgper 7.6 Gram(s)DSLD:175305
Bodybuilding.com Platinum SeriesAMP'D Recovery Orange Mango750 mgper 7.3 Gram(s)DSLD:175311
Bodybuilding.com Platinum SeriesAMP'D Recovery Watermelon750 mgper 7.8 Gram(s)DSLD:175314
Bodybuilding.com Platinum SeriesPost Protocol Black Cherry2 Gram(s)per 23 Gram(s)DSLD:64288
Bodybuilding.com Platinum SeriesPost Protocol Fruit Punch2 Gram(s)per 22 Gram(s)DSLD:64287
Bodybuilding.com SignatureAmino Plus Energy Blueberry Lemonade1 Gram(s)per 10 Gram(s)DSLD:202969
Bodybuilding.com SignatureAmino Plus Energy Tropical Pineapple1 Gram(s)per 11 Gram(s)DSLD:203201
Bodybuilding.com SignatureAmino Plus Energy Watermelon Lime1 Gram(s)per 10 Gram(s)DSLD:203202
Bodybuilding.com SignatureBCAA Blue Raspberry1 Gram(s)per 7.4 Gram(s)DSLD:199994
Bodybuilding.com SignatureBCAA Blueberry Lemonade1 Gram(s)per 8 Gram(s)DSLD:203204
Bodybuilding.com SignatureBCAA Cherry Limeade1 Gram(s)per 7.4 Gram(s)DSLD:199996
Bodybuilding.com SignatureBCAA Fruit Punch1 Gram(s)per 7.1 Gram(s)DSLD:200053
Bodybuilding.com SignatureBCAA Tropical Pineapple1 Gram(s)per 8 Gram(s)DSLD:203205
Bodybuilding.com SignatureBCAA Watermelon Lime1 Gram(s)per 8 Gram(s)DSLD:200054
BodyLogixNatural BCAA Green Applefermented from vegan sources1,250 mgper 8.2 Gram(s)DSLD:314859
BodyTechBCAAL-Valine Note: free form amino acid600 mgper 3 Capsule(s)DSLD:204648
BodyTechBCAAL-Valine Note: free form amino acid600 mgper 3 Capsule(s)DSLD:245180
BodyTechBCAAL-Valine Note: free form amino acid600 mgper 3 Capsule(s)DSLD:64693
BodyTechBCAA + Glutamine UnflavoredL-Valine Note: free form amino acid1 Gram(s)per 6.9 Gram(s)DSLD:183485
BodyTechBCAA + Glutamine UnflavoredL-Valine Note: free form amino acid1 Gram(s)per 6.9 Gram(s)DSLD:183487
BodyTechBCAA UnflavoredL-Valine Note: free form amino acid1.25 Gram(s)per 5 Gram(s)DSLD:64732
BodyTechCritical Aminos XT Blue Ice Pop625 mgper 7.8 Gram(s)DSLD:184597
BodyTechCritical Aminos XT Fruit Punch625 mgper 10 Gram(s)DSLD:183762
BodyTechCritical Aminos XT Grape625 mgper 7.1 Gram(s)DSLD:183639
BodyTechCritical Aminos XT Pineapple625 mgper 7.4 Gram(s)DSLD:183663
BodyTechCritical Aminos XT Sweet Tea625 mgper 7.3 Gram(s)DSLD:184033
BodyTechCritical Aminos XT Watermelon625 mgper 10.1 Gram(s)DSLD:184323
BodyTechInstantized BCAA Fruit Punch1.25 Gram(s)per 7.3 Gram(s)DSLD:184319
BodyTechInstantized BCAA UnflavoredL-Valine Note: free form amino acid1.25 Gram(s)per 5.6 Gram(s)DSLD:245230
BodyTech EliteUltimate BCAA Fruit Punch1,750 mgper 15.5 Gram(s)DSLD:204853
BodyTech EliteUltimate BCAA Grape1,750 mgper 15.6 Gram(s)DSLD:204862
BodyTech EliteUltimate BCAA Strawberry Kiwi1,750 mgper 15.6 Gram(s)DSLD:204916
BodyTech EliteUltimate BCAA Watermelon Candy1,750 mgper 15.6 Gram(s)DSLD:204855
BodyTech EliteUltimate EAA Fruit Punch1,500 mgper 14.7 Gram(s)DSLD:208824
BodyTech EliteUltimate EAA Grape1,500 mgper 15 Gram(s)DSLD:208744
BPI SportsBulk Muscle Chocolate Peanut ButterL-Valine Note: naturally occurring from protein1.7 Gram(s)per 168 Gram(s)DSLD:43309
BPI SportsBulk Muscle Cookies and CreamL-Valine Note: from protein complex matrix1.75 Gram(s)per 165 Gram(s)DSLD:41630
BPI SportsBulk Muscle Cookies and CreamL-Valine Note: naturally occurring from protein1.7 Gram(s)per 168 Gram(s)DSLD:43304
BPI SportsBulk Muscle Whipped VanillaL-Valine Note: naturally occurring from protein1.7 Gram(s)per 165 Gram(s)DSLD:43310
Bricker LabsAmino Supreme166 mgper 5 Tablet(s)DSLD:3182
BronsonAmino Acid ComplexValine Note: Essential Amino Acids42 mgper 1 Tablet(s)DSLD:8461
Bronson LaboratoriesAll Insurance Vitamin Powder63 mgper 8.76 Gram(s)DSLD:25265
Bucked UpOriginal BCAA 2:1:1 Apple Jacked1,500 mgper 10.67 Gram(s)DSLD:269121
Bucked UpRacked Branched Chain Amino Acids Grape1,000 mgper 10.84 Gram(s)DSLD:269524
BulkSupplements.comBCAA 2:1:1440 mgper 2000 mgDSLD:252404
BulkSupplements.comBCAA 2:1:1375 mgper 3 Vegetarian Capsule(s)DSLD:252414
BulkSupplements.comBCAA 2:1:1440 mgper 4 Capsule(s)DSLD:253383
BulkSupplements.comBCAA 2:1:1440 mgper 2000 mgDSLD:253390
BulkSupplements.comBCAA 2:1:1440 mgper 4 Capsule(s)DSLD:253409
BulkSupplements.comBCAA 2:1:1375 mgper 3 Capsule(s)DSLD:253425
BulkSupplements.comBCAA 2:1:1500 mgper 4 Capsule(s)DSLD:295062
BulkSupplements.comBCAA 2:1:1500 mgper 2000 mgDSLD:295063
BulkSupplements.comBCAA 2:1:1500 mgper 2000 mgDSLD:295065
BulkSupplements.comBCAA 2:1:1500 mgper 2000 mgDSLD:295066
BulkSupplements.comBCAA 2:1:11,500 mgper 6000 mgDSLD:310663
BulkSupplements.comBCAA 2:1:11,500 mgper 6000 mgDSLD:310962
BulkSupplements.comBCAA 2:1:11,500 mgper 6000 mgDSLD:310963
BulkSupplements.comBCAA 2:1:11,500 mgper 6000 mgDSLD:310964
BulkSupplements.comBCAA 2:1:1500 mgper 4 Capsule(s)DSLD:310965
BulkSupplements.comBCAA 2:1:1500 mgper 4 Capsule(s)DSLD:310966
BulkSupplements.comBCAA 2:1:1 1000 mg250 mgper 2 Capsule(s)DSLD:310664
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:252409
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:253415
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:253419
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:253423
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:310967
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:310968
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:310969
BulkSupplements.comBCAA 3:1:2500 mgper 1500 mgDSLD:310970
BulkSupplements.comBCAA 3:1:2 Powder 1500 mg500 mgper 1500 mgDSLD:330319
BulkSupplements.comBCAA 3:1:2 Powder 1500 mg500 mgper 1500 mgDSLD:330320
BulkSupplements.comBCAA 3:1:2 Powder 1500 mg500 mgper 1500 mgDSLD:330321
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:254888
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:254889
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:254890
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:252851
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:312300
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:312301
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:312302
BulkSupplements.comL-Valine2,000 mgper 2000 mgDSLD:312303
California Academy of HealthWhey Protein Gold Isolate Plus Natural Chocolate Flavor1,382 mgper 44 Gram(s)DSLD:191162
California Academy of HealthWhey Protein Gold Isolate Plus Natural Vanilla Flavor1,533 mgper 6 TbspDSLD:197375
California Gold Nutrition SPORTBCAA fermented1.25 Gram(s)per 5 Gram(s)DSLD:299579
CellucorCOR-Performance B-BCAA Lemon-Lime1.25 gper 11.4 Gram(s)DSLD:18927
CellucorCOR-Performance B-BCAA Lemon-Lime1.25 Gram(s)per 9 Gram(s)DSLD:82876
CellucorCOR-Performance B-BCAA Tropical Punch1.25 gper 11.3 Gram(s)DSLD:18929
CellucorCOR-Performance B-BCAA Tropical Punch1.25 Gram(s)per 9 Gram(s)DSLD:82880
CellucorCOR-Performance B-BCAA Watermelon1.25 gper 11.5 Gram(s)DSLD:18928
CellucorCOR-Performance B-BCAA Watermelon1.25 Gram(s)per 9 Gram(s)DSLD:82881
CellucorCOR-Performance BCAA 2:1:1 Cherry Limeade1.5 Gram(s)per 8.5 Gram(s)DSLD:82885
CellucorCOR-Performance BCAA 2:1:1 Cherry Limeade1.5 Gram(s)per 8.5 Gram(s)DSLD:82886
CellucorCOR-Performance BCAA 2:1:1 Icy Blue Razz1.5 Gram(s)per 8.5 Gram(s)DSLD:82882
CellucorCor-Performance Beta-BCAA1.25 gper 11.4 Gram(s)DSLD:18971
CGM LabsOnce A Day Albumin Complex20 mgper 1 Chewable Tablet(s)DSLD:301440
Clean MachineClean BCAA Fruit Punch1,000 mgper 7.2 Gram(s)DSLD:307873
Clean MachineClean BCAA Lemonade1,000 mgper 7.4 Gram(s)DSLD:307874
Clean MachineClean BCAA Watermelon1,000 mgper 7.6 Gram(s)DSLD:307875
Combat NutraBattle Buddy Fruit Punch1,000 mgper 6.5 Gram(s)DSLD:249643
Country LifeIron Tek Hydro Recovery Coconut flavorL-Valine Note: vegan250 mgper 4.9 Gram(s)DSLD:79109
Country LifeIron Tek Hydro Recovery Coconut FlavorL-Valine Note: vegan250 mgper 4.9 Gram(s)DSLD:79099
Country LifeMax-Amino Caps with Vitamin B6L-Valine Note: free form amino acid150 mgper 4 Capsule(s)DSLD:208012
Country LifeMax-Amino Caps with Vitamin B6L-Valine Note: free form amino acid150 mgper 4 Capsule(s)DSLD:208016
Creative BiosciencePure BCAA Unflavored1,000 mgper 5.2 Gram(s)DSLD:79179
CymbiotikaPure Hydration Lemon Citrus75 mgper 8 Gram(s)DSLD:304740
CymbiotikaPure Hydration Lychee75 mgper 8 Gram(s)DSLD:304739
CymbiotikaPure Hydration Watermelon75 mgper 8 Gram(s)DSLD:304293
D.Bal.MaxD.Bal.Max100 mgper 3 Capsule(s)DSLD:268023
DaVinci LaboratoriesAmino 2115 mgper 1 Capsule(s)DSLD:322151
DCFree-Form AminosL-Valine Note: (Essential Amino Acid) (Branched Chain Amino Acid)33 mgper 1 Tablet(s)DSLD:245133
Designs for HealthAmino Acid Synergy300 mgper 4 Capsule(s)DSLD:22323
Do VitaminsBCAAL-Valine (Alt. Name: AjiPure)525 mgper 1 Capsule(s)DSLD:269487
Do VitaminsBCAA Powder UnflavoredAjiPure1,250 mgper 5 Gram(s)DSLD:269497
Do VitaminsPostPump UnflavoredL-Valine (Alt. Name: AjiPure)750 mgper 7.75 Gram(s)DSLD:269521
Do VitaminsPurePump LemonAjiPure250 mgper 4.48 Gram(s)DSLD:269537
Do VitaminsPurePump UnflavoredAjiPure250 mgper 3.8 Gram(s)DSLD:269534
Double Wood SupplementsEssential Amino Acids141 mgper 3 Capsule(s)DSLD:241772
Douglas LaboratoriesAmino Gram ForteL-Valine Note: One of 10 essential Amino Acids.71.5 mgper 1 Tablet(s)DSLD:57724
Douglas LaboratoriesBranched Chain Amino Acid150 mgper 1 Capsule(s)DSLD:5380
Douglas LaboratoriesBranched Chain Amino Acids150 mgper 1 Capsule(s)DSLD:8825
Douglas LaboratoriesL-Valine 500 mg500 mgper 1 Capsule(s)DSLD:9287
Douglas LaboratoriesPro-Shake 19 Natural Vanilla Protein Powder418 mgper 15 Gram(s)DSLD:9404
Douglas LaboratoriesUltra Anabolic92 mgper 1 Capsule(s)DSLD:8361
Douglas LaboratoriesUltra Protein Plus Natural Vanilla Bean Flavor940 mgper 31.6 Gram(s)DSLD:30694
Dr. Clark Research Association Dr. Clark ZentrumBranch Chained Amino Acids 500 mg900 mgper 6 Capsule(s)DSLD:223141
Dr. Clark Research Association Dr. Clark ZentrumEssential Amino Acids 500 mg450 mgper 6 Capsule(s)DSLD:223131
Dr. Rico PerezAmino Complex32 mgper 1 Capsule(s)DSLD:321008
Drucker LabsintraMAX 2.0 Peach Mango Flavoramount not statedper 1 fl. Oz.DSLD:236722
DymatizeBCAAs Blue Raspberry1.2 Gram(s)per 9 Gram(s)DSLD:83002
DymatizeBCAAs Cherry Limeade1.2 Gram(s)per 9 Gram(s)DSLD:83005
DymatizeBCAAs Watermelon1.2 Gram(s)per 9 Gram(s)DSLD:83009
Dymatize NutritionBCAA Complex 5050 Branched Chain Amino Acids Pink Lemonade1.26 Gram(s)per 9 Gram(s)DSLD:53042
EAEnhanced EAA + Blood Orange2,000 mgper 7.6 Gram(s)DSLD:321428
EA EnhancedAnabolic IV Tropical2,000 mgper 7.6 Gram(s)DSLD:223079
Enriching GiftsAmino Acids34 mgper 2 Capsule(s)DSLD:228176
EquatePost Workout Fruit Punch1.2 Gram(s)per 7.8 Gram(s)DSLD:272969
EquipPure Pre Blackberry Lemon425 mgper 19.2 Gram(s)DSLD:332846
Everyday DoseMushroom Coffee+113 mgper 7 Gram(s)DSLD:315153
Everyday DoseMushroom Matcha+122 mgper 7 Gram(s)DSLD:317537
Evlution NutritionBCAA 1000250 mgper 2 Capsule(s)DSLD:326366
Evlution NutritionBCAA 5000 Cherry Limeade1,250 mgper 8.3 Gram(s)DSLD:302086
Evlution NutritionBCAA 5000 Fruit Punch1,250 mgper 8.1 Gram(s)DSLD:326367
Evlution NutritionBCAA 5000 Furious Grape1,250 mgper 8.6 Gram(s)DSLD:326368
Evlution NutritionBCAA 5000 Lemon Lime1,250 mgper 8.6 Gram(s)DSLD:302087
Evlution NutritionBCAA 5000 Unflavored1,250 mgper 5 Gram(s)DSLD:302062
Evlution NutritionBCAA 5000 Unflavored1,250 mgper 5 Gram(s)DSLD:326369
Evlution NutritionBCAA50001,250 mgper 8 Capsule(s)DSLD:302061
Evlution NutritionBCAA5000 Blue Raz1,250 mgper 8 Gram(s)DSLD:302085
Evlution NutritionLeanBCAA Fruit Punch1,250 mgper 7.9 Gram(s)DSLD:302122
EvogenAmino K.E.M.750 mgper 5 Tablet(s)DSLD:300193
Fahrenheit NutritionEndurance BCAA Plus1.8 gper 13.5 Gram(s)DSLD:19244
FINAFLEXEAA Psycho Peach1,250 mgper 13.4 Gram(s)DSLD:333668
FitLinePROSHAPE (Amino)13.02%448 mgper 6 Capsule(s)DSLD:321599
FN Formutech NutritionEndurance BCAA+ Melon1.8 Gram(s)per 14.47 Gram(s)DSLD:261044
FN Formutech NutritionEndurance BCAA+ Orange1.8 Gram(s)per 14.47 Gram(s)DSLD:261045
FN Formutech NutritionEndurance BCAA+ Sweet Tea1.8 Gram(s)per 15 Gram(s)DSLD:259061
FN Formutech NutritionFit Men12.5 mgper 3 Capsule(s)DSLD:259062
FN Formutech NutritionFit Women12.5 mgper 3 Capsule(s)DSLD:259064
FoodScience of VermontAmino Max 2115 mgper 1 Capsule(s)DSLD:74925
G GainfulGainful Pre-Workout Sour Watermelon500 mgper 10 Gram(s)DSLD:252036
G6 SportsMass Pro ChocolateL-Valine3,442 mgper 219 Gram(s)DSLD:269036
G6 SportsMass Pro High Protein Mass Gainer ChocolateL-Valine3,442 mgper 219 Gram(s)DSLD:267987
G6 SportsMass Pro High Protein Mass Gainer VanillaL-Valine3,519 mgper 43.8 Gram(s)DSLD:269280
G6 SportsMass Pro VanillaL-Valine3,519 mgper 219 Gram(s)DSLD:269038
G6 SportsReplenish Orange Mangofrom natural and artificial sources1,358 mgper 55.3 Gram(s)DSLD:269005
Garden of LifeRaw Organic Fit Chocolate FlavorEssential Amino Acids, Branched Chain Amino Acids1,440 mgper 45.5 Gram(s)DSLD:297638
Gaspari NutritionBCAA 60001,000 mgper 6 Tablet(s)DSLD:228168
Gaspari NutritionBCAA 60001,000 mgper 6 Tablet(s)DSLD:80189
GAT SportJetMASS Strawberry Lemonade250 mgper 23.6 Gram(s)DSLD:276597
GenesaTotal Amino SolutionL-Valine · Valine (Form: as L-Valine)150 mgper 3 Vegi-Capsule(s)DSLD:205996
GNC AMP Advanced Muscle PerformanceMega Men Sport MultivitaminL-Valine50 mgper 2 Mocha Brown Timed-Release Caplet(s)DSLD:312637
GNC AMP Advanced Muscle PerformanceMega Men Sport Multivitamin50 mgper 2 Mocha Brown Caplet(s)DSLD:312702
GNC AMP Advanced Muscle PerformanceMega Men Sport Multivitamin50 mgper 2 Mocha Brown Caplet(s)DSLD:317645
GNC AMP Advanced Muscle PerformanceWheybolic Chocolate FudgeL-Valine, Micronized · Valine (Form: from Whey Protein isolate, micronized L-Valine, hydrolyzed Whey Protein)2.5 Gram(s)per 62.5 Gram(s)DSLD:220074
GNC AMP Advanced Muscle PerformanceWheybolic Chocolate FudgeL-Valine, Micronized · Valine (Form: from Whey Protein isolate, micronized L-Valine, hydrolyzed Whey Protein)2.5 Gram(s)per 62.5 Gram(s)DSLD:243050
GNC AMP Advanced Muscle PerformanceWheybolic Classic VanillaL-Valine, Micronized · L-Valine (Form: from Whey Protein Isolate, micronized L-Valine, hydrolyzed Whey Protein)1.25 Gram(s)per 61.5 Gram(s)DSLD:228524
GNC Beyond RawmTOR Matrix200 mgper 2 White Capsule(s)DSLD:63771
GNC Beyond RawPrecision Amino Crisp Apple2 Gram(s)per 20.6 Gram(s)DSLD:330844
GNC Beyond RawPrecision Amino Gummy Worm2 Gram(s)per 21.83 Gram(s)DSLD:327389
GNC Beyond RawPrecision Amino Peach Mango Tea2 Gram(s)per 21.43 Gram(s)DSLD:330845
GNC Mega MenSport Multivitamin50 mgper 2 Caplet(s)DSLD:334082
GNC Mega MenSport Multivitamin50 mgper 2 Caplet(s)DSLD:334083
GNC MilestonesMuscle Function Complex175 mgper 2 White Capsule(s)DSLD:65755
GNC Pro PerformanceAmino Complex 4400700 mgper 8 Capsule(s)DSLD:2715
GNC Pro PerformanceBCAA 1800270 mgper 6 Capsule(s)DSLD:74854
GNC Pro PerformanceBCAA 1800 mg270 mgper 6 Capsule(s)DSLD:309076
GNC Pro PerformanceBCAA 1800 mg270 mgper 6 Capsule(s)DSLD:315320
GNC Pro PerformanceBCAA Complex Chew Tropical Punch350 mgper 2 Chew(s)DSLD:74828
GNC Pro PerformanceBCAA Unflavored1,000 mgper 5.3 Gram(s)DSLD:78476
GNC Pro PerformanceHybrid Creatine Complex Fruit Punch250 mgper 48.17 Gram(s)DSLD:25606
GNC Pro PerformanceHybrid Creatine Complex Unflavored250 mgper 48.64 Gram(s)DSLD:27358
GNC Pro PerformanceNighttime Restore50 mgper 2 White Capsule(s)DSLD:30570
GNC Pro PerformanceRapidDrive BCAA 5000 Fruit Punch1,000 mgper 7 Gram(s)DSLD:66893
GNC Pro PerformanceRapidDrive BCAA 5000 Unflavored1,000 mgper 5.3 Gram(s)DSLD:2719
GNC Pro PerformanceRapidDrive Post-Workout Amino Complex Fruit Punch1,800 mgper 17 Gram(s)DSLD:2723
GNC Pro PerformanceRapidDrive Pre-Workout Amino Complex Fruit Punch1,000 mgper 15.5 Gram(s)DSLD:2722
GNC Pro PerformanceUltra Amino Complex Fruit Punch1,200 mgper 14.07 Gram(s)DSLD:16385
GNC Pro PerformanceUltra Amino Complex Fruit Punch1.2 Gram(s)per 14.07 Gram(s)DSLD:207201
GNC Pro PerformanceUltra Amino Complex Watermelon1,200 mgper 13.98 Gram(s)DSLD:25704
GNC Pro PerformanceXR Series BCAA Advanced XR Berry Fusion2 Gram(s)per 10.6 Gram(s)DSLD:74587
GNC Pro Performance AMPAmplified Endurance Booster Blue Raspberry50 mgper 60 Gram(s)DSLD:18529
GNC Pro Performance AMPAmplified Endurance Booster Blue Raspberry50 mgper 60 Gram(s)DSLD:5862
GNC Pro Performance AMPAmplified Endurance Booster Orange50 mgper 61 Gram(s)DSLD:5864
GNC Pro Performance AMPAmplified Push Blue RaspberryL-Valine · Valine (Form: as L-Valine, Whey Protein isolate)1.5 Gram(s)per 16.25 Gram(s)DSLD:48182
GNC Pro Performance AMPMuscle Function Formula50 mgper 2 Capsule(s)DSLD:45115
GNC Pro Performance AMPWomen's Advanced Protein Chocolate CupcakeWhey Protein Concentrate · Valine (Form: as Whey Protein concentrate, Whey Protein isolate)800 mgper 26.5 Gram(s)DSLD:70292
GNC Pro Performance AMPWomen's Advanced Protein Cinnamon BunWhey Protein Concentrate · Valine (Form: as Whey Protein concentrate, Whey Protein isolate)800 mgper 25.3 Gram(s)DSLD:69507
GNC Pro Performance AMPWomen's Advanced Protein Vanilla Ice CreamWhey Protein Concentrate · Valine (Form: as Whey Protein concentrate, Whey Protein isolate)800 mgper 26.5 Gram(s)DSLD:74605
GNC Women'sAdvanced Collagen Formula12 mgper 1 Capsule(s)DSLD:79168
Gorilla MindGorilla Mode EAAS Jungle Juice2,000 mgper 14.1 Gram(s)DSLD:301117
Gorilla MindGorilla Mode EAAS Lemon Lime2,000 mgper 14.1 Gram(s)DSLD:274368
GPS Genesis Pure SportsPro-Arginine250 mgper 1 Level Scoop(s)DSLD:70413
Great Lakes Gelatin Co.Collagen Hydrolysate Apple + Cucumber FlavoredValine Note: Essential Amino Acids264 mgper 13 Gram(s)DSLD:230087
GymFloOvercome Candy Tart2.5 Gram(s)per 31.5 Gram(s)DSLD:208721
Hard RhinoBCAA 2:1:1 1200 mg300 mgper 2 Capsule(s)DSLD:71752
Hard RhinoBCAA 2:1:1 3000 mg750 mgper 5 Capsule(s)DSLD:71750
Hard RhinoInstantized BCAA 2:1:11,250 mgper 5 Gram(s)DSLD:71762
Hard RhinoInstantized BCAA 2:1:11,250 mgper 5 Gram(s)DSLD:71754
Hard RhinoInstantized BCAA 2:1:11,250 mgper 5 Gram(s)DSLD:71860
Hard RhinoInstantized BCAA 2:1:1 Blue Raspberry1,250 mgper 6.56 Gram(s)DSLD:71759
Hard RhinoInstantized BCAA 2:1:1 Blue Raspberry1,250 mgper 6.56 Gram(s)DSLD:71763
Hard RhinoInstantized BCAA 2:1:1 Fruit Punch1,250 mgper 6.285 Gram(s)DSLD:71760
Hard RhinoInstantized BCAA 2:1:1 Fruit Punch1,250 mgper 6.285 Gram(s)DSLD:71764
HARD RHINOPure BCAA 2:1:1 Instant Grade Powder1,250 mgper 10 Gram(s)DSLD:34279
Healthy 'N FitAnabolic Amino BCAA1,739 mgper 3 Caplet(s)DSLD:262210
Herbs SRAEnergyPlus+60 mgper 2 Capsule(s)DSLD:316147
Highland LaboratoriesMuscle Dynamics50 mgper 11 Gram(s)DSLD:80034
Hollywood SuppsBranched Chain-Amino CapsulesL-Valine Note: free-form800 mgper 4 Capsule(s)DSLD:199730
HTLTWhey Protein Vanilla Peanut Butter1,332 mgper 32 Gram(s)DSLD:265454
IMSOALPHAAlpha Carb Fruit Punch1,000 mgper 33 Gram(s)DSLD:216984
IMSOALPHABCAA Grape1,000 mgper 6.5 Gram(s)DSLD:256162
IMSOALPHABCAA Lemon Lime1,000 mgper 6.5 Gram(s)DSLD:256180
IMSOALPHABCAA Watermelon1,000 mgper 6.5 Gram(s)DSLD:256183
Infinite LabsBCAA750 mgper 6 Capsule(s)DSLD:42412
Integrative TherapeuticsMercury Detox200 mgper 2 Capsule(s)DSLD:77926
InterActive NutritionBCAA Muscle Guard808 mgper 4 Capsule(s)DSLD:2438
Irwin NaturalsTriple Shredder Body-Shaper250 mgper 3 Liquid Soft-Gel(s)DSLD:239454
Irwin NaturalsTriple Shredder Body-Shaper100 mgper 3 Liquid Softgel(s)DSLD:292098
Jacked Factory Essential SeriesBCAA 6000 mg Fruit Punch1,500 mgper 8.5 Gram(s)DSLD:257522
Jacked Factory Essential SeriesBCAA 6000 mg Unflavored1,500 mgper 6 Gram(s)DSLD:261411
JayLab ProBCAA400 mgper 2 Capsule(s)DSLD:221025
JJJ DistributorsKH-622.23 mgper 6 Tablet(s)DSLD:26749
Julian BakeryPegan Thin Seed Protein 20 g Triple Chocolatebranched chain amino acid, essential amino acids800 mgper 44 Gram(s)DSLD:296710
JYMPre JYM Cherry Limeade1.5 Gram(s)per 26.5 Gram(s)DSLD:207898
JYMPre JYM Orange Mango1.5 Gram(s)per 26.5 Gram(s)DSLD:207840
JYMPre JYM Raspberry Lemonade1.5 Gram(s)per 26.5 Gram(s)DSLD:207893
JYMPre JYM Raspberry Lemonade1.5 Gram(s)per 26.5 Gram(s)DSLD:207901
JYM Supplement ScienceBCAAs Grape Candy1.5 Gram(s)per 9 Gram(s)DSLD:286241
JYM Supplement ScienceBCAAs Green Apple1.5 Gram(s)per 9 Gram(s)DSLD:287322
JYM Supplement SciencePost JYM BCAAs+ Recovery Matrix Blue Arctic Freeze1.2 Gram(s)per 21 Gram(s)DSLD:216080
JYM Supplement SciencePost JYM BCAAs+ Recovery Matrix Fruit Punch1.2 Gram(s)per 21 Gram(s)DSLD:334773
JYM Supplement SciencePost JYM BCAAs+ Recovery Matrix Rainbow Sherbet1.2 Gram(s)per 19 Gram(s)DSLD:334774
JYM Supplement SciencePre JYM Black Cherry1.5 Gram(s)per 26 Gram(s)DSLD:286244
JYM Supplement SciencePre JYM Cherry Limeade1.5 Gram(s)per 13 Gram(s)DSLD:334771
JYM Supplement SciencePre JYM Grape Candy1.5 Gram(s)per 25 Gram(s)DSLD:286245
JYM Supplement SciencePre JYM High-Performance Pre-Workout Rainbow Sherbet1.5 Gram(s)per 27 Gram(s)DSLD:286247
JYM Supplement SciencePre JYM Natural Island Punch1.5 Gram(s)per 26 Gram(s)DSLD:252280
JYM Supplement SciencePre JYM Natural Island Punch1.5 Gram(s)per 26 Gram(s)DSLD:74216
JYM Supplement SciencePre JYM Pineapple Strawberry1.5 Gram(s)per 13 Gram(s)DSLD:217574
JYM Supplement SciencePre JYM Pineapple Strawberry1.5 Gram(s)per 26 Gram(s)DSLD:286246
JYM Supplement SciencePre JYM Pink Lemonade1.5 Gram(s)per 12.5 Gram(s)DSLD:217569
JYM Supplement SciencePre JYM Pink Lemonade1.5 Gram(s)per 12.5 Gram(s)DSLD:335180
JYM Supplement SciencePre JYM Rainbow Sherbet1.5 Gram(s)per 13.5 Gram(s)DSLD:217595
JYM Supplement SciencePre JYM Refreshing Melon1.5 Gram(s)per 13 Gram(s)DSLD:217815
JYM Supplement SciencePre JYM Refreshing Melon1.5 Gram(s)per 26 Gram(s)DSLD:252281
JYM Supplement SciencePre JYM Strawberry Kiwi1.5 Gram(s)per 13 Gram(s)DSLD:217814
JYM Supplement SciencePre JYM Strawberry Kiwi1.5 Gram(s)per 13 Gram(s)DSLD:286248
JYM Supplement SciencePre JYM Tangerine1.5 Gram(s)per 25 Gram(s)DSLD:286249
JYM Supplement SciencePre JYM Tangerine1.5 Gram(s)per 25 Gram(s)DSLD:312646
KagedBCAA 2:1:1 Unflavoredfermented1.25 Gram(s)per 5.5 Gram(s)DSLD:298709
Kaged MuscleBCAA 2:1:1 UnflavoredL-Valine Note: fermented1.25 Gram(s)per 5.5 Gram(s)DSLD:202108
Kaged MuscleBCAA 2:1:1 UnflavoredL-Valine Note: fermented1.25 Gram(s)per 5.5 Gram(s)DSLD:202136
KionAminos500 mgper 7 Capsule(s)DSLD:307219
KirkmanAmino Support Powder260 mgper 1 tspDSLD:23882
Klean AthleteKlean BCAA + Peak ATP Orange Flavor1 Gram(s)per 8.6 Gram(s)DSLD:293246
Lake Avenue NutritionBranched-Chain Amino AcidsFree-form650 mgper 4 Veggie Capsule(s)DSLD:272298
Lake Avenue NutritionInstantized BCAA Unflavored1.25 Gram(s)per 5.3 Gram(s)DSLD:272385
Lake Avenue NutritionInstantized BCAA Unflavored1.25 Gram(s)per 5 Gram(s)DSLD:319371
Leading Edge HealthGenFX2.86 mgper 1 Capsule(s)DSLD:336110
Leading Edge HealthHyperGH 14x160 mgper 2 Tablet(s)DSLD:339437
Lee Haney's Nutritional Support SystemsCompetitive MassWhey Protein1,245 mgper 65 Gram(s)DSLD:12990
LidtkeGlycoTrolL-Valine Note: (USP) (As certified by the manufacturer)103 mgper 1 Capsule(s)DSLD:215171
LidtkeGlycoTrol CompleteL-Valine Note: USP100 mgper 1 Capsule(s)DSLD:215165
LidtkeGlycoTrol CompleteL-Valine Note: USP103 mgper 1 Capsule(s)DSLD:257254
LidtkeGlycoTrol CompleteL-Valine Note: USP103 mgper 1 Capsule(s)DSLD:257285
LidtkeGlycoTrol CompleteL-Valine Note: USP103 mgper 1 Capsule(s)DSLD:261009
Life ExtensionBranched Chain Amino Acids (Free Form)600 mgper 4 Capsule(s)DSLD:231773
Life ExtensionBranched Chain Amino Acids (Free Form)600 mgper 4 Capsule(s)DSLD:328302
Lifestyle Fitness & NutritionBCAA Force Branched Chain Amino Acids500 mgper 2 Capsule(s)DSLD:16965
LiveGoodEssential Aminos Delicious Fruit Punch Flavor450 mgper 10.14 Gram(s)DSLD:339347
MacroLife NaturalsMacroMeal Ultimate ChocolateEssential amino acids783.5 mgper 45 Gram(s)DSLD:295312
MacroLife NaturalsMacroMeal Ultimate Chocolateessential amino acids1,567 mgper 22.5 Gram(s)DSLD:295313
MacroLife NaturalsMacroMeal Ultimate Chocolate Protein PowderAmino acids, essential amino acidsamount not statedper 45 Gram(s)DSLD:288254
MacroLife NaturalsMacroMeal Ultimate Chocolate Protein PowderAmino acids, essential amino acidsamount not statedper 22.5 Gram(s)DSLD:293340
MacroLife NaturalsMacroMeal Ultimate Chocolate Protein Powderessential amino acidsamount not statedper 22.5 Gram(s)DSLD:293341
MacroLife NaturalsMacroMeal Ultimate Chocolate Protein PowderAmino acids, essential amino acidsamount not statedper 22.5 Gram(s)DSLD:293342
MacroLife NaturalsMacroMeal Ultimate VanillaAmino acids, essential amino acidsamount not statedper 40 Gram(s)DSLD:292749
MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids, essential amino acidsamount not statedper 40 Gram(s)DSLD:288255
MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids, essential amino acidsamount not statedper 41 Gram(s)DSLD:288256
MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids, essential amino acids1,427 mgper 40 Gram(s)DSLD:292747
MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids, essential amino acidsamount not statedper 40 Gram(s)DSLD:292748
MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids, essential amino acidsamount not statedper 41 Gram(s)DSLD:292755
MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids, essential amino acids1,512 mgper 41 Gram(s)DSLD:292756
MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids, essential amino acidsamount not statedper 41 Gram(s)DSLD:292757
Market AmericaTorch After-Burn Recovery Drink Creamy Vanilla Flavor250 mgper 43 Gram(s)DSLD:6204
Martin Avenue PharmacyAmino Acids Formula71.5 mgper 1 Tablet(s)DSLD:18766
Max Effort MusclePre Workout Raspberry Punch500 mgper 12.2 Gram(s)DSLD:240233
MBi NutraceuticalsBio-Aminos163 mgper 2 Capsule(s)DSLD:231378
MET-RxBCAA 2200500 mgper 4 Softgel(s)DSLD:73342
MET-RxBCAA 5000 Blue RaspberryL-Valine Note: 1.5 g1,500 mgper 6.5 Gram(s)DSLD:63881
MET-RxBCAA 5000 UnflavoredL-Valine Note: 1.5 g1,500 mgper 5 Gram(s)DSLD:66278
MET-RxBCAA 5000 WatermelonL-Valine Note: 1.5 g1,500 mgper 6.5 Gram(s)DSLD:64039
MET-RxTimed-Release BCAA 1800400 mgper 2 Caplet(s)DSLD:34121
Metabolic MaintenanceBCAA+ Branched Chain Amino Acids175 mgper 1 Capsule(s)DSLD:24739
MetagenicsBCAAs Orange Mango Flavor1.5 Gram(s)per 7.3 Gram(s)DSLD:295631
MHP Maximum Human PerformanceBCAA 3300550 mgper 4 Tablet(s)DSLD:5717
MillecorAminos Watermelon1,000 mgper 6.5 Gram(s)DSLD:317781
MM Sports NutritionEnduroMAX Natural Lemon Lime Flavor500 mgper 61.7 Gram(s)DSLD:38180
MN Morphogen NutritionVegagen Almond BlissInstAminos · vegan fermented250 mgper 37.5 Gram(s)DSLD:261249
MN Morphogen NutritionVegagen SnickerdoodleInstAminos · vegan fermented250 mgper 38.1 Gram(s)DSLD:261251
MontiffAll- Basic 677 Milligramsamount not statedper 1 Capsule(s)DSLD:42000
MontiffSuper-Sportsamount not statedper 1 Capsule(s)DSLD:237087
MontiffSuper-Sports 750 Milligramsamount not statedper 1 Capsule(s)DSLD:293563
MontiffSuper-Sports 750 Milligramsamount not statedper 1 Capsule(s)DSLD:42099
Moss NutritionAminoSelect330 mgper 1 Capsule(s)DSLD:306480
MRMBCAA+G Green Apple1,500 mgper 6.5 Gram(s)DSLD:178962
MRMBCAA+G RELOAD LemonadeL-Valine Note: fermented1,000 mgper 13.8 Gram(s)DSLD:178976
MRM NutritionBCAA+G 1000 Green Apple Flavoredfermented1,500 mgper 6.5 Gram(s)DSLD:305015
MRM NutritionBCAA+G 1000 Lemonade Flavoredfermented1,500 mgper 6.5 Gram(s)DSLD:319058
MRM NutritionBCAA+G 6,000Fermented1,500 mgper 6 Capsule(s)DSLD:319059
MRM NutritionBCAA+G Lemonade FlavoredFermented1,500 mgper 6.5 Gram(s)DSLD:305017
MRM NutritionBCAA+G RELOAD Island Fusion FlavoredFermented1,000 mgper 12.5 Gram(s)DSLD:319060
MRM NutritionBCAA+G RELOAD Lemonade FlavoredFermented1,000 mgper 12.5 Gram(s)DSLD:319061
MRM NutritionRELOAD BCAA+G Watermelon FlavoredFermented1,000 mgper 12.5 Gram(s)DSLD:319062
MRM NutritionRELOAD BCAA+G Watermelon FlavoredFermented1,000 mgper 12.5 Gram(s)DSLD:319063
Mt. CapraCaproteinValine Note: Essential amino acids548 mgper 10 Gram(s)DSLD:4743
Mt. CapraDouble Bonded Protein Chocolate1,221 mgper 33.5 Gram(s)DSLD:19314
MTN OPSBCAA Strawberry Dragonfruitamount not statedper 12 Gram(s)DSLD:277540
Muscle FeastAll Natural BCAA 4:1:1 Mango Peachvegan925 mgper 6.6 Gram(s)DSLD:262852
Muscle FeastBCAA 4:1:1 Blue Ice Pop Flavorvegan833 mgper 8.3 Gram(s)DSLD:261355
Muscle FeastBCAA 4:1:1 Green Apple Flavorvegan833 mgper 8.3 Gram(s)DSLD:262851
Muscle FeastBCAA 4:1:1 Tangerine Flavorvegan833 mgper 8.3 Gram(s)DSLD:262853
Muscle FeastBCAA 4:1:1 Unflavoredvegan907 mgper 5.5 Gram(s)DSLD:262854
Muscle FeastBCAA 4:1:1 Watermelon Flavorvegan833 mgper 8.3 Gram(s)DSLD:262855
Musclegen Performance NutritionBCAA Watermelon1,000 mgper 6.5 Gram(s)DSLD:249692
Musclegen Performance NutritionElite-Intra Atomic Fruit Blast2 Gram(s)per 18 Gram(s)DSLD:220775
MusclePharmBCAA 3:1:22,000 mcgper 6 Capsule(s)DSLD:3713
MusclePharmBCAA 3:1:22,000 mgper 8 Capsule(s)DSLD:82242
MusclePharmBCAA 3:1:2 Blue Raspberry2,000 mgper 7.16 Gram(s)DSLD:38871
MusclePharmBCAA 3:1:2 Watermelon2,000 mgper 7.16 Gram(s)DSLD:38879
MusclePharm MP EssentialsBCAA2 Gram(s)per 8 Capsule(s)DSLD:265419
MusclePharm MP EssentialsBCAA Blue Raspberry2 Gram(s)per 7.5 Gram(s)DSLD:265420
MusclePharm MP EssentialsBCAA Blue Raspberry2 Gram(s)per 7.5 Gram(s)DSLD:267244
MusclePharm MP EssentialsBCAA Fruit Punch2 Gram(s)per 8.6 Gram(s)DSLD:265421
MusclePharm MP EssentialsBCAA Fruit Punch2 Gram(s)per 8.6 Gram(s)DSLD:267253
MusclePharm MP EssentialsBCAA Grape2 Gram(s)per 7.86 Gram(s)DSLD:265422
MusclePharm MP EssentialsBCAA Grape2 Gram(s)per 7.86 Gram(s)DSLD:267254
MusclePharm MP EssentialsBCAA Lemon Lime2 Gram(s)per 7.8 Gram(s)DSLD:265423
MusclePharm MP EssentialsBCAA Lemon Lime2 Gram(s)per 7.8 Gram(s)DSLD:267270
MusclePharm MP EssentialsBCAA Orange Mango2 Gram(s)per 7.5 Gram(s)DSLD:265424
MusclePharm MP EssentialsBCAA Unflavored2 Gram(s)per 6.5 Gram(s)DSLD:265425
MusclePharm MP EssentialsBCAA Watermelon2 Gram(s)per 7.2 Gram(s)DSLD:265426
MuscleTech100% Mass Gainer Chocolate Fudge BrownieL-Valine · L-Valine (Form: as Whey Protein, L-Valine)3.6 Gram(s)per 359 Gram(s)DSLD:255834
MuscleTechMass Tech Cookies and CreamCalcium Caseinate4.8 Gram(s)per 230 Gram(s)DSLD:267879
MusclTech100% Mass Gainer Vanilla MilkshakeL-Valine3.6 Gram(s)per 357 Gram(s)DSLD:267861
MyologyBCAA 2200500 mgper 4 Softgel(s)DSLD:286452
Nature's SunshineFree Amino Acids70 mgper 2 Tablet(s)DSLD:255231
Natures CraftBCAA750 mgper 3 Tablet(s)DSLD:256244
NaturesPlusGH MALEFree-Form Amino Acid50 mgper 2 Capsule(s)DSLD:303941
NewtonEverettAminoForce32 mgper 1 Capsule(s)DSLD:292148
NewtonEverettBCAA Plus Branched Chain Amino Acid Grape1,750 mgper 12 Gram(s)DSLD:34731
NewtonEverettWhey Protein Chocolate100 mgper 28 Gram(s)DSLD:82693
NewtonEverettWhey Protein Natural Vanilla Flavor100 mgper 21.5 Gram(s)DSLD:34730
NOW SportsAmino-9 Essentials421 mgper 3 Tablet(s)DSLD:12882
NOW SportsAmino-9 Essentials421 mgper 3 Tablet(s)DSLD:12883
NOW SportsAmino-9 Essentials Powder518 mgper 5.6 Gram(s)DSLD:314237
NOW SportsBranched Chain Amino AcidsL-Valine Note: free-form650 mgper 4 Capsule(s)DSLD:210321
NOW SportsBranched-Chain Amino Acid PowderL-Valine Note: (free-form) (1,100 mg)1.1 Gram(s)per 2 tspDSLD:210371
NOW SportsBranched-Chain Amino Acid PowderL-Valine Note: (free-form) (1,100 mg)1.1 Gram(s)per 5.2 Gram(s)DSLD:314250
NOW SportsBranched-Chain Amino AcidsL-Valine Note: free-form650 mgper 4 Capsule(s)DSLD:210353
NOW SportsBranched-Chain Amino AcidsL-Valine Note: free-form650 mgper 4 Capsule(s)DSLD:210320
NOW SportsElectro Endurance Natural Orange FlavorL-Valine Note: free-form500 mgper 45 Gram(s)DSLD:205226
NOW SportsElectro Endurance Orange FlavorL-Valine Note: free-form500 mgper 45 Gram(s)DSLD:13117
NutivaOrganic MCT Protein Chocolate Flavored1 Gram(s)per 10 Gram(s)DSLD:251283
NutivaOrganic MCT Protein Vanilla Flavored1 Gram(s)per 39 Gram(s)DSLD:250822
NutraBio100% Pure L-Valine2,000 mgper 2 Gram(s)DSLD:51008
NutraBioBCAA 2500L-Valine Note: (naturally fermented) (vegan)625 mgper 5 Vegetable Capsule(s)DSLD:213014
NutraBioBCAA 2500L-Valine Note: (naturally fermented) (vegan)625 mgper 5 Vegetable Capsule(s)DSLD:213019
NutraBioBCAA 2500fermented625 mgper 5 Vegetable Capsule(s)DSLD:329338
NutraBioBCAA 2500 500 mg625 mgper 5 Capsule(s)DSLD:248384
NutraBioBCAA 5000 Blue RaspberryL-Valine Note: fermented - vegan1.25 Gram(s)per 7.4 Gram(s)DSLD:248586
NutraBioBCAA 5000 Dragonfruit CandyL-Valine Note: fermented - vegan1.25 Gram(s)per 7.75 Gram(s)DSLD:248599
NutraBioBCAA 5000 Dragonfruit Candyfermented - vegan1.25 Gram(s)per 7.75 Gram(s)DSLD:329341
NutraBioBCAA 5000 Grape1,250 mgper 6.24 Gram(s)DSLD:174976
NutraBioBCAA 5000 GrapeL-Valine Note: (naturally fermented) (vegan)1.25 Gram(s)per 6.24 Gram(s)DSLD:80001
NutraBioBCAA 5000 Grape Berry Crushfermented, vegan1.25 Gram(s)per 7.74 Gram(s)DSLD:309313
NutraBioBCAA 5000 Kiwi Strawberry1.25 Gram(s)per 6.69 Gram(s)DSLD:248195
NutraBioBCAA 5000 Kiwi Strawberryfermented1,250 mgper 6.69 Gram(s)DSLD:329342
NutraBioBCAA 5000 Lemon LimeL-Valine Note: (naturally fermented) (vegan)1.25 Gram(s)per 6.19 Gram(s)DSLD:79991
NutraBioBCAA 5000 Lemonadefermented1,250 mgper 6.97 Gram(s)DSLD:329343
NutraBioBCAA 5000 Passion FruitL-Valine Note: (naturally fermented) (vegan)1.25 Gram(s)per 6.36 Gram(s)DSLD:79970
NutraBioBCAA 5000 Pina ColadaL-Valine Note: (naturally fermented) (vegan)1.25 Gram(s)per 6.62 Gram(s)DSLD:79958
NutraBioBCAA 5000 Raw Unflavored1.25 Gram(s)per 5 Gram(s)DSLD:248197
NutraBioBCAA 5000 Raw Unflavoredfermented1,250 mgper 5 Gram(s)DSLD:329344
NutraBioBCAA 5000 Strawberry Lemon BombL-Valine Note: fermented - vegan1.25 Gram(s)per 7.96 Gram(s)DSLD:248615
NutraBioBCAA 5000 Strawberry Lemonade1,250 mgper 7.54 Gram(s)DSLD:309311
NutraBioBCAA 5000 Sun TeaL-Valine Note: (naturally fermented) (vegan)1.25 Gram(s)per 6.92 Gram(s)DSLD:248391
NutraBioBCAA 5000 Tropical Fruit PunchL-Valine Note: (naturally fermented) (vegan)1.25 Gram(s)per 6.44 Gram(s)DSLD:79975
NutraBioBCAA 5000 Watermelon1.25 Gram(s)per 6.33 Gram(s)DSLD:248200
NutraBioL-Valine 450 Milligrams450 mgper 2 Vegetable Capsule(s)DSLD:50816
NutraBio NaturalsBCAA 5000 Lemonade1.25 Gram(s)per 6.97 Gram(s)DSLD:248196
NutraKey Health Performance BCAA358 mgper 3 Capsule(s)DSLD:287384
NutraOneAminoOne Strawberry Pineapple1,250 mgper 7.5 Gram(s)DSLD:304925
Nutrex ResearchAmino Drive Black Bruisin' Berry1,500 mgper 14 Gram(s)DSLD:29971
Nutrex ResearchAmino Drive Black Gashin' Grape1,500 mgper 14.2 Gram(s)DSLD:29973
Nutrex ResearchAmino Drive Black Malicious Melon1,500 mgper 13.7 Gram(s)DSLD:29975
Nutrex ResearchAmino Drive Fruit Punch1.5 Gram(s)per 13.6 Gram(s)DSLD:52840
Nutrex ResearchAmino Drive Green Apple1.5 Gram(s)per 14.5 Gram(s)DSLD:52841
Nutrex Research Black SeriesAmino Drive Blackberry Lemonade1.25 Gram(s)per 8 Gram(s)DSLD:176153
Nutrex Research Black SeriesAmino Drive Peach Pineapple1.25 Gram(s)per 8.1 Gram(s)DSLD:176156
Nutrex Research Black SeriesAmino Drive Strawberry Kiwi1.25 Gram(s)per 8.7 Gram(s)DSLD:176162
Nutrex Research Black SeriesAmino Drive Wild Cherry Citrus1.25 Gram(s)per 8.6 Gram(s)DSLD:176155
Nutrex Research Black SeriesBCAA Drive1.25 Gram(s)per 5 Tablet(s)DSLD:176182
Nutri-WestComplete-FM22 mgper 2 Tablet(s)DSLD:27600
Nutri-WestCore Level Pancreas10 mgper 1 Tablet(s)DSLD:27730
Nutri-WestSpore-X31.7 mgper 1 Tablet(s)DSLD:28250
NutriCologySuper Immuno Complex28 mgper 1 Packet(s)DSLD:183928
ON Optimum NutritionBCAA 1000250 mgper 2 Capsule(s)DSLD:319464
ON Optimum NutritionBCAA 1000 Caps 1,000 mg250 mgper 2 Capsule(s)DSLD:29073
ON Optimum NutritionBCAA 5000 Powder Unflavored1.25 Gram(s)per 11.5 Gram(s)DSLD:57619
ON Optimum NutritionInstantized BCAA 5000 Powder1.25 gper 5.75 Gram(s)DSLD:17615
ON Optimum NutritionInstantized BCAA 5000 Powder Fruit Punch1.25 Gram(s)per 9.5 Gram(s)DSLD:218736
ON Optimum NutritionInstantized BCAA 5000 Powder Orange1.25 gper 9.5 Gram(s)DSLD:17594
ON Optimum NutritionMega-Size BCAA 1000 Caps250 mgper 2 Capsule(s)DSLD:29075
ON Optimum NutritionPre-Load Creatine Complex Fruit Punch500 mgper 1 Scoop(s)DSLD:13927
Optimum NutritionBCAA 1000 Caps250 mgper 2 Capsule(s)DSLD:58706
Optimum NutritionMega-Size BCAA 1000 Caps250 mgper 2 Capsule(s)DSLD:258965
Optimum NutritionMega-Size BCAA 1000 Caps250 mgper 2 Capsule(s)DSLD:308429
Parrillo PerformanceUltimate Amino Formula124 mgper 2 Capsule(s)DSLD:322532
Potent SeaMarine Aminos25 mgper 2 Capsule(s)DSLD:17197
Power BlendzRecovery384 mgper 6.5 Gram(s)DSLD:263917
Power BlendzStrength384 mgper 6 Gram(s)DSLD:263919
Power Blendz NutritionBCAA Pro Formula750 mgper 3 Tablet(s)DSLD:263643
Power Blendz NutritionBCAA Pro Formula750 mgper 3 Tablet(s)DSLD:318654
Precision EngineeredAmino 1000L-Valine Note: essential amino acids40 mgper 2 Caplet(s)DSLD:2461
Precision EngineeredBCAA 2200500 mgper 4 Softgel(s)DSLD:21340
Precision EngineeredBCAA PowderL-Valine Note: 1.5 g1,500 mgper 5 Gram(s)DSLD:21204
Precision EngineeredBCAA Powder Lemon-LimeL-Valine Note: 1.5 g1,500 mgper 6 Gram(s)DSLD:18166
Precision EngineeredBCAA Powder WatermelonL-Valine Note: 1.5 g1,500 mgper 6.4 Gram(s)DSLD:21348
Precision EngineeredLiquid Aminos Wild Cherry FlavorL-Valine Note: essential amino acids342 mgper 2 TbspDSLD:21045
Precision EngineeredTimed Release BCAA 900 mg400 mgper 2 Caplet(s)DSLD:21342
Premium CertifiedBCAA 2:1:1 with BioPerine600 mgper 2 Tablet(s)DSLD:308051
ProCapsEssential Amino Proteinessential amino acids, branched chain amino acids150 mgper 4 Capsule(s)DSLD:331548
Progressive Professional from Progressive LaboratoriesAmino Blend120 mgper 3 Capsule(s)DSLD:261202
Promuscle ProductsAmino 8:1:1+L-Glutamine Blue Raz Flavour6.8 Gram(s)per 1 Scoop(s)DSLD:211366
Propello LifeRejuvenating Non-GMO Aminos Cherries & Vanilla1.25 Gram(s)per 10.7 Gram(s)DSLD:69562
PS ProSuppsHydroBCAA Blue Razz1.75 Gram(s)per 13.6 Gram(s)DSLD:47730
PS ProSuppsHydroBCAA LemonLime1.75 Gram(s)per 13.3 Gram(s)DSLD:47732
PS ProSuppsHydroBCAA Pineapple1.75 Gram(s)per 13.5 Gram(s)DSLD:47733
PS ProSuppsHydroBCAA Pineapple1.75 Gram(s)per 13.5 Gram(s)DSLD:47771
PureBCAA375 mgper 3 Capsule(s)DSLD:248623
Pure EncapsulationsAmino RepleteL-Valine Note: free-form300 mgper 9 Gram(s)DSLD:184274
Pure EncapsulationsAmino Repletefree-form300 mgper 4 Gram(s)DSLD:293886
Pure EncapsulationsAmino-NRL-Valine Note: free-form113 mgper 3 Capsule(s)DSLD:245985
Pure EncapsulationsAmino-NRFree-form113 mgper 3 Capsule(s)DSLD:293887
Pure EncapsulationsEssential Aminos75 mgper 1 Capsule(s)DSLD:261613
Pure PowerEAA + BCAA Orange1,500 mgper 11.6 Gram(s)DSLD:327158
PureBulk.comL-Valine2,000 mgper 1000 mgDSLD:23153
Puritan's PrideEssential Aminos Complexfree form75 mgper 1 Vegetable Capsule(s)DSLD:318139
RackedBCAA Blood Raz1,000 mgper 9.61 Gram(s)DSLD:229055
RackedBCAA Peach Mango1,000 mgper 9.72 Gram(s)DSLD:229056
RackedBCAA Pina Colada1,000 mgper 9.27 Gram(s)DSLD:229057
RackedBCAA Watermelon1,000 mgper 9.63 Gram(s)DSLD:229058
Reaction NutritionBCAA 2:1:1500 mgper 3 Capsule(s)DSLD:19582
Redcon1Grunt Blood Orange15.8 Gram(s)per 9.5 Gram(s)DSLD:269167
Redcon1Grunt Cherry Lime15.8 Gram(s)per 9.5 Gram(s)DSLD:269116
Redcon1Grunt Pineapple Banana1.5 Gram(s)per 9.5 Gram(s)DSLD:269166
Redcon1Grunt Tiger's Blood1.5 Gram(s)per 9.5 Gram(s)DSLD:236985
Revolution Nutrition Pro SeriesBCAA Splash Blue Raspberry900 mgper 5.5 Gram(s)DSLD:232598
Ryno PowerRecoveryBranched-Chain Amino Acids250 mgper 3 Capsule(s)DSLD:255753
ScivationXTEND Lemon Lime Sour1,750 mgper 12.8 Gram(s)DSLD:13369
Scivation XTENDElite Island Punch Flavor1,750 mgper 19.5 Gram(s)DSLD:82434
Scivation XTENDElite Sour Gummy Flavor1,750 mgper 19.8 Gram(s)DSLD:82438
Seeking HealthOptimal Amino Blend42 mgper 1 Capsule(s)DSLD:210883
ShredzBCAA + Glutamine Fruit Punch800 mgper 9.86 Gram(s)DSLD:36649
Signature Supplements9 Essential Amino Acids97 mgper 2 Capsule(s)DSLD:338587
Six Star Pro NutritionAmino Max Fruit Punch1,000 mgper 8 Gram(s)DSLD:62848
SolgarBCAA Plus Branched Chain Amino AcidsL-Valine Note: free form300 mgper 2 Vegetable Capsule(s)DSLD:71680
SomaLifeYouth Formula400 mgper 6 Capsule(s)DSLD:16517
SomaLife InternationalgHP Sport400 mgper 6 Capsule(s)DSLD:16512
Source NaturalsBCAA450 mgper 3 Capsule(s)DSLD:209439
Source NaturalsBCAA450 mgper 3 Capsule(s)DSLD:210778
Source NaturalsBCAA450 mgper 3 Capsule(s)DSLD:214428
SP Standard ProcessSP Detox Balance900 mgper 37 Gram(s)DSLD:340373
SteelADABolic Candy Bliss1.75 Gram(s)per 37 Gram(s)DSLD:277714
SteelBCAA + EAA1.25 Gram(s)per 10 Gram(s)DSLD:266712
SteelVeg-Pro Vanilla Cream Pie1.06 Gram(s)per 1 Scoop(s)DSLD:218137
STI Presents G6 SportsReplenish Candy Watermelon1,358 mgper 55.3 Gram(s)DSLD:327606
STI Presents G6 SportsReplenish Fruit Punch1,358 mgper 55.3 Gram(s)DSLD:323692
STI Presents G6 SportsReplenish Mixed Berry1,358 mgper 55.3 Gram(s)DSLD:327607
SuperSmartBCAA's2,500 mgper 2 Scoop(s)DSLD:285311
SwansonBCAA513 mgper 3 Capsule(s)DSLD:308485
SwansonVitality Renewal Formula1.5 mcgper 12 Drop(s)DSLD:206865
SyntraxAmino-Tor Blue Raspberry1,500 mgper 11 Gram(s)DSLD:228545
SyntraxAmino-Tor Juicy Watermelon1,500 mgper 11 Gram(s)DSLD:228547
SyntraxAmino-Tor Orange Citrus1,500 mgper 11 Gram(s)DSLD:228550
SyntraxAmino-Tor Pink Lemonade1,500 mgper 11 Gram(s)DSLD:228551
SyntraxAmino-Tor Strawberry Kiwi1,500 mgper 11 Gram(s)DSLD:228552
SyntraxAmino-Tor Tangy Mango1,500 mgper 11 Gram(s)DSLD:228553
SyntraxMatrix 1.0 Milk ChocolateValine Note: (Branched-Chain Amino Acid) (Essential Amino Acid)6 Gram(s)per 31 Gram(s)DSLD:228586
SyntraxMatrix Amino Blue Raspberry500 mgper 12 Gram(s)DSLD:228556
SyntraxMatrix Amino Juicy Watermelon500 mgper 12 Gram(s)DSLD:228560
SyntraxMatrix Amino Orange Citrus500 mgper 12 Gram(s)DSLD:228563
SyntraxMatrix Amino Pink Lemonade500 mgper 12 Gram(s)DSLD:228570
SyntraxMatrix Amino Strawberry Kiwi500 mgper 12 Gram(s)DSLD:228571
SyntraxMatrix Amino Tangy Mango500 mgper 12 Gram(s)DSLD:228572
Systemic FormulasAccell Therapeutic367 mgper 30 Gram(s)DSLD:22284
Systemic FormulaseNRG LQ Quantum Cellular ATP Energyamount not statedper 0.5 Dropper(s)DSLD:22506
Systemic FormulasEventa LQamount not statedper 0.5 Dropper(s)DSLD:22400
Systemic Formulas Bio NutrimentPro Nutro Protein3 mgper 1 Capsule(s)DSLD:22040
Tapout Sports NutritionRecover Post Workout12.5 mgper 66 Gram(s)DSLD:2126
Taylor MD FormulationsAmino Restore Natural Choclate Flavor1.47 Gram(s)per 15 Gram(s)DSLD:263101
Ten PerformancePro BCAA1.25 Gram(s)per 6 Gram(s)DSLD:287117
The Genius BrandGenius BCAA Power OrangeVegan1.25 Gram(s)per 13.8 Gram(s)DSLD:263173
The Vitamin ShoppeCritical Aminos XT Strawberry Lemonade625 mgper 10.1 Gram(s)DSLD:183879
ThorneAmino Complex Berry Flavored625 mgper 7.6 Gram(s)DSLD:328818
ThorneAmino Complex Berry Flavored625 mgper 7.6 Gram(s)DSLD:337851
ThorneAmino Complex Lemon Flavored625 mgper 7.7 Gram(s)DSLD:323098
ThorneAmino Complex Lemon Flavored625 mgper 7.7 Gram(s)DSLD:336309
ThorneSynaQuell625 mgper 7.8 Gram(s)DSLD:337875
TN Trusted NutrientsBCAA 2200 mg500 mgper 4 Softgel(s)DSLD:70276
tnvitaminsBCAA 2000 mg500 mgper 4 Tablet(s)DSLD:217696
Tokkyo NutritionBCAA Stack Watermelon1,750 mgper 12.5 Gram(s)DSLD:180485
TriVitaLeanology ChocolateValine Note: Essential Amino Acids (amount in 30.3g of powder)808 mgper 30.3 Gram(s)DSLD:33082
True AthleteBCAA Powder 4:1:1 Ratio1 Gram(s)per 6.7 Gram(s)DSLD:207946
True AthleteEndurance and Recovery Fruit Punch1,250 mgper 12.2 Gram(s)DSLD:221237
True AthleteEndurance and Recovery Grape1,250 mgper 12 Gram(s)DSLD:213890
True AthleteEndurance and Recovery Grape1,250 mgper 12 Gram(s)DSLD:221536
True AthleteFermented BCAA 4:1:11,000 mgper 6.7 Gram(s)DSLD:221519
True AthleteNatural Recovery Mixed Berry1,250 mgper 10.25 Gram(s)DSLD:217915
TruehopeAminopowerplusL-Valine Hydrochloride · Valine (Form: as L-valine hydrochloride)132 mgper 4 Veggie Capsule(s)DSLD:32348
Twinlab100% Whey Protein Fuel Chocolate Surge1,480 mgper 35 Gram(s)DSLD:4265
Twinlab100% Whey Protein Fuel Strawberry Smash1,480 mgper 34 Gram(s)DSLD:3623
Twinlab100% Whey Protein Fuel Vanilla Slam1,480 mgper 33 Gram(s)DSLD:3624
TwinlabAmino Fuel 1000281 mgper 4 Tablet(s)DSLD:3625
TwinlabAmino Fuel 1000281 mgper 4 Tablet(s)DSLD:73907
Ultimate Nutrition100% Crystalline BCAA 500 mgUSP600 mgper 3 Capsule(s)DSLD:293445
UniversalAmino 1000L-Valine · Valine (Form: as L-Valine)459 mgper 5 Capsule(s)DSLD:64048
UniversalAmino 1900320 mgper 4 Tablet(s)DSLD:246059
UniversalAmino 1900320 mgper 4 Tablet(s)DSLD:274619
UniversalAmino 1900340 mgper 4 Tablet(s)DSLD:64049
UniversalAmino 2250L-Valine · Valine (Form: as L-Valine)202 mgper 2 Tablet(s)DSLD:37728
UniversalAmino 2250202 mgper 2 Tablet(s)DSLD:64054
UniversalAmino 2250202 mgper 2 Tablet(s)DSLD:64059
UniversalAmino 2700354 mgper 3 Tablet(s)DSLD:37770
UniversalAmino 2700354 mgper 3 Tablet(s)DSLD:65618
UniversalAtomic 7 'Lectric Lemon Lime2 Gram(s)per 13.1 Gram(s)DSLD:64099
UniversalAtomic 7 'Lectric Lemon Lime2 Gram(s)per 13.1 Gram(s)DSLD:64122
UniversalAtomic 7 Black Cherry Bomb2 Gram(s)per 12.9 Gram(s)DSLD:64095
UniversalAtomic 7 Black Cherry Bomb2 Gram(s)per 12.9 Gram(s)DSLD:64119
UniversalAtomic 7 Groovy Grape2 Gram(s)per 13.71 Gram(s)DSLD:64097
UniversalAtomic 7 Groovy Grape2 Gram(s)per 13.71 Gram(s)DSLD:64126
UniversalAtomic 7 Rockin' Razz Lemonade2 Gram(s)per 13.41 Gram(s)DSLD:37789
UniversalAtomic 7 Rockin' Razz Lemonade2 Gram(s)per 13.41 Gram(s)DSLD:64128
UniversalAtomic 7 Way Out Watermelon2 Gram(s)per 12.78 Gram(s)DSLD:64102
UniversalAtomic 7 Way Out Watermelon2 Gram(s)per 12.78 Gram(s)DSLD:64113
UniversalBCAA 2000L-Valine · Valine (Form: as L-Valine)934 mgper 2 Capsule(s)DSLD:64131
UniversalBCAA ProL-Valine250 mgper 2 Capsule(s)DSLD:275307
UniversalBCAA PROL-Valine · Valine (Form: as L-Valine)250 mgper 2 Capsule(s)DSLD:246198
UniversalBCAA Stack Grape Splash1.25 Gram(s)per 10 Gram(s)DSLD:64183
UniversalBCAA Stack Lemon Lime1.25 Gram(s)per 9.2 Gram(s)DSLD:37889
UniversalBCAA Stack Lemon Lime1.25 Gram(s)per 9.2 Gram(s)DSLD:64187
UniversalBCAA Stack Orange Splash1.25 Gram(s)per 9.34 Gram(s)DSLD:64178
UniversalBCAA Stack Orange Splash1.25 Gram(s)per 9.34 Gram(s)DSLD:64190
UniversalUniversal Amino 2700330 mgper 3 Tablet(s)DSLD:247363
UniversalUniversal BCAA Stack Grape Splash1.25 Gram(s)per 10 Gram(s)DSLD:65619
Universal NutritionUniversal Amino 2700330 mgper 3 Tablet(s)DSLD:274726
Vibrant HealthPureGreen Potein Chocolate510 mgper 37.57 Gram(s)DSLD:42558
Vibrant HealthPureGreen Potein Chocolate510 mgper 37.57 Gram(s)DSLD:42817
Vibrant HealthPureGreen Potein Chocolate510 mgper 37.57 Gram(s)DSLD:42821
Vibrant HealthPureGreen Protein Chocolate510 mgper 37.57 Gram(s)DSLD:42561
Vibrant HealthPureGreen Protein Mixed Berry510 mgper 30.17 Gram(s)DSLD:38318
Vibrant HealthPureGreen Protein Mixed Berry510 mgper 30.17 Gram(s)DSLD:42365
Vibrant HealthPureGreen Protein Mixed Berry510 mgper 30.17 Gram(s)DSLD:42551
Vibrant HealthPureGreen Protein Mixed Berry510 mgper 30.17 Gram(s)DSLD:42556
Vibrant HealthPureGreen Protein Natural510 mgper 28.74 Gram(s)DSLD:42822
Vibrant HealthPureGreen Protein Natural510 mgper 28.74 Gram(s)DSLD:42828
Vibrant HealthPureGreen Protein Natural510 mgper 28.74 Gram(s)DSLD:42829
Vibrant HealthPureGreen Protein Natural510 mgper 28.74 Gram(s)DSLD:42830
Vibrant HealthPureGreen Protein Vanilla510 mgper 31.34 Gram(s)DSLD:43081
Vibrant HealthPureGreen Protein Vanilla510 mgper 31.34 Gram(s)DSLD:43082
Vibrant HealthPureGreen Protein Vanilla510 mgper 31.34 Gram(s)DSLD:43083
ViMulti Beautiful MeBCAA Amino Essentials750 mgper 3 Tablet(s)DSLD:230844
Vital NutrientsBranched Chain AminosUSP270 mgper 3 Vegetarian Capsule(s)DSLD:304957
VMI SportsAminogex Ultra Miami Vice1,750 mgper 17.2 Gram(s)DSLD:257498
VMI SportsAminogex Ultra Red Fruit Candy1,750 mgper 17.2 Gram(s)DSLD:257499
VMI SportsAminogex Ultra Tropical Mango1,750 mgper 17.2 Gram(s)DSLD:257500
VMI SportsAminogex Ultra Watermelon1,750 mgper 17.2 Gram(s)DSLD:257497
VPXCREmTOR500 mgper 6 Gram(s)DSLD:51508
VPXCREmTOR Watermelon500 mgper 7.6 Gram(s)DSLD:39470
VPXCREmTOR Watermelon500 mgper 7.6 Gram(s)DSLD:51510
VPXCREmTOR Wild Grape500 mgper 7.1 Gram(s)DSLD:51505
Wonder LabsAmino Acid ComplexL-Valine Note: (Essential Amino Acid) (Branched Chain Amino Acid)33 mgper 1 Tablet(s)DSLD:214914
Wonder LabsAmino Acid Complex(Essential Amino Acid) (Branched Chain Amino Acid)33 mgper 1 Tablet(s)DSLD:260733
Worldwide NutritionBCAA Mango Colada1,250 mgper 14.1 Gram(s)DSLD:287532
Worldwide NutritionBCAA Watermelon1,250 mgper 14.1 Gram(s)DSLD:287533
XTENDElite Citrus Passionfruit1,750 mgper 18 Gram(s)DSLD:228992
XTENDElite Citrus Passionfruit1,750 mgper 18 Gram(s)DSLD:229004
XTENDElite Fraserade1,750 mgper 18.5 Gram(s)DSLD:229746
XTENDElite Island Punch Fusion1,750 mgper 18 Gram(s)DSLD:228941
XTENDElite Island Punch Fusion1,750 mgper 18 Gram(s)DSLD:228998
XTENDElite Pre Mango Madness1,750 mgper 13.5 Gram(s)DSLD:249085
XTENDElite Pre Strawberry Kiwi Splash1,750 mgper 13.5 Gram(s)DSLD:229868
XTENDElite Pre Watermelon Explosion1,750 mgper 13.5 Gram(s)DSLD:229876
XTENDElite Sour Gummy Flavor1,750 mgper 18 Gram(s)DSLD:228986
XTENDElite Sour Gummy Flavor1,750 mgper 18 Gram(s)DSLD:229001
XTENDEnergy Blue Raspberry Ice1,750 mgper 11.6 Gram(s)DSLD:229086
XTENDEnergy Knockout Fruit Punch1,750 mgper 11.6 Gram(s)DSLD:229014
XTENDEnergy Mango Madness1,750 mgper 11.6 Gram(s)DSLD:229082
XTENDKeto Energy Knockout Fruit Punch1,750 mgper 17 Gram(s)DSLD:229220
XTENDKeto Energy Ultra Frost1,750 mgper 16.5 Gram(s)DSLD:229745
XTENDKeto Orange Mango1,750 mgper 16.6 Gram(s)DSLD:229156
XTENDKeto Strawberry Kiwi Splash1,750 mgper 17.2 Gram(s)DSLD:229201
XTENDRipped Blueberry Lemonade1,750 mgper 16.5 Gram(s)DSLD:228723
XTENDRipped Strawberry Kiwi Splash1,750 mgper 16.5 Gram(s)DSLD:228782
XTENDRipped Watermelon Lime1,750 mgper 16.5 Gram(s)DSLD:228772
XTENDSport Blue Raspberry Ice1,750 mgper 11.5 Gram(s)DSLD:261338
XTENDSport Strawberry Kiwi Splash1,750 mgper 11.5 Gram(s)DSLD:292456
XTENDThe Original Black Cherry1,750 mgper 13.5 Gram(s)DSLD:240942
XTENDThe Original Blue Raspberry Ice1,750 mgper 14 Gram(s)DSLD:228580
XTENDThe Original Blue Raspberry Ice1,750 mgper 14 Gram(s)DSLD:229101
XTENDThe Original Blue Raspberry Ice1,750 mgper 14 Gram(s)DSLD:254294
XTENDThe Original Blue Raspberry Ice1,750 mgper 14 Gram(s)DSLD:292457
XTENDThe Original Blueberry Lemonade1,750 mgper 14.7 Gram(s)DSLD:295112
XTENDThe Original Freedom Ice1,750 mgper 14 Gram(s)DSLD:295113
XTENDThe Original Glacial Grape1,750 mgper 13.5 Gram(s)DSLD:228587
XTENDThe Original Glacial Grape1,750 mgper 13.5 Gram(s)DSLD:295110
XTENDThe Original Italian Blood Orange1,750 mgper 14.5 Gram(s)DSLD:244190
XTENDThe Original Italian Blood Orange1,750 mgper 14.5 Gram(s)DSLD:292458
XTENDThe Original Knockout Fruit Punch1,750 mgper 13.5 Gram(s)DSLD:228681
XTENDThe Original Knockout Fruit Punch1,750 mgper 13.5 Gram(s)DSLD:278240
XTENDThe Original Lemon-Lime Squeeze1,750 mgper 14 Gram(s)DSLD:295111
XTENDThe Original Lemon-Lime Squeeze1,750 mgper 14 Gram(s)DSLD:296441
XTENDThe Original Mango Madness1,750 mgper 14 Gram(s)DSLD:229150
XTENDThe Original Mango Madness1,750 mgper 14 Gram(s)DSLD:295114
XTENDThe Original Mango Madness1,750 mgper 14 Gram(s)DSLD:295115
XTENDThe Original Smash Apple1,750 mgper 14 Gram(s)DSLD:228709
XTENDThe Original Smash Apple1,750 mgper 14 Gram(s)DSLD:292459
XTENDThe Original Strawberry Kiwi Splash1,750 mgper 14 Gram(s)DSLD:228712
XTENDThe Original Strawberry Kiwi Splash1,750 mgper 14 Gram(s)DSLD:229145
XTENDThe Original Strawberry Kiwi Splash1,750 mgper 14 Gram(s)DSLD:292461
XTENDThe Original Strawberry Kiwi Splash1,750 mgper 14.7 Gram(s)DSLD:295116
XTENDThe Original Tropic Thunder1,750 mgper 14 Gram(s)DSLD:228719
XTENDThe Original Tropic Thunder1,750 mgper 14 Gram(s)DSLD:292460
XTENDThe Original Watermelon Explosion1,750 mgper 13 Gram(s)DSLD:228538
XTENDThe Original Watermelon Explosion1,750 mgper 13 Gram(s)DSLD:229114
XTENDThe Original Watermelon Explosion1,750 mgper 13 Gram(s)DSLD:292462
XTENDXTEND Blue Raspberry Ice1,750 mgper 16.9 Fluid Ounce(s)DSLD:229752
XTENDXTEND Kiwi Berry Blast1,750 mgper 1 Can(s)DSLD:321645
XTENDXTEND Mango Madness1,750 mgper 16.9 Fluid Ounce(s)DSLD:229758
XtendlifeCardio-Klenz100 mgper 6 Tablet(s)DSLD:17014
XtendlifeCardio-Support100 mgper 6 Tablet(s)DSLD:82166
XtendlifeNeuro-Natural General100 mgper 3 Tablet(s)DSLD:82170
XtendlifeNeuro-Natural Serenity50 mgper 3 Tablet(s)DSLD:82185
XtendlifeNeuro-Natural Sleep50 mgper 3 Tablet(s)DSLD:82194
XYMOGENOptiCleanse Plus Rice Original1,692 mgper 53 Gram(s)DSLD:6563
XYMOGENOptiCleanse Plus Rice Raspberry Lemonade250 mgper 60 Gram(s)DSLD:6562
XYMOGENXymoBolX Natural Lemon Flavor427 mgper 6.8 Gram(s)DSLD:335572
ZHOUBCAA 2:1:1 2500 mg625 mgper 4 Vegetable Capsule(s)DSLD:250042
ZHOUMuscle BCAA Tropical Punch2,500 mgper 11 Gram(s)DSLD:313669

Label record: NIH Office of Dietary Supplements · CC0

Registered, and not reported

Source: ClinicalTrials.gov
Intervention: L-valine
Status: Completed, terminated or suspended
Results posted: No

Trials without posted results

230 trials

230 registered trials without posted results · Overdue (FDAAA 801): 112 · Showing 120 of 230

112 past the window8 within it, or no actual date

Order

NCT03508739suspended— We do not have active funding at this time.expected 2026-06-01a university or hospital
NCT05705414completed2026-05-30a university or hospital
NCT07544888completed2026-03-01a university or hospital
NCT07379788completed2026-02-28a university or hospital
NCT05528419completed2026-01-22a university or hospital
NCT05638880completed2025-12-20a university or hospital
NCT04603443completed2025-09-30US federal agencypast the reporting window
NCT03476616completed2025-06-30a university or hospitalpast the reporting window
NCT07088471completed2025-05-01a university or hospitalpast the reporting window
NCT05920005completed2025-03-31a university or hospitalpast the reporting window
NCT03872778completed2025-01-07industrypast the reporting window
NCT07327749completed2024-12-01a university or hospitalpast the reporting window

Show the remaining 218

NCT04774068completed2024-10-27a university or hospitalpast the reporting window
NCT03553810completed2024-06-28a university or hospitalpast the reporting window
NCT05095922completed2024-05-30a university or hospitalpast the reporting window
NCT06125730completed2024-02-10industrypast the reporting window
NCT05359068completed2023-12-26industrypast the reporting window
NCT06487949completed2023-10-01a university or hospitalpast the reporting window
NCT07700875completed2023-08-20industrypast the reporting window
NCT03576612completed2023-06-30industrypast the reporting window
NCT03928158completed2023-06-30a government bodypast the reporting window
NCT05881720completed2023-06-18a university or hospitalpast the reporting window
NCT05681273completed2023-03-21industrypast the reporting window
NCT05291559completed2022-09-07a university or hospitalpast the reporting window
NCT03432741terminated— funding - sponsor filing Chapter 11 bankruptcy2022-08-26a university or hospitalpast the reporting window
NCT03893435completed2022-07-01a research networkpast the reporting window
NCT06088550completed2022-06-30a university or hospitalpast the reporting window
NCT05152849completed2022-06-21industrypast the reporting window
NCT03711903completed2022-06-16a university or hospitalpast the reporting window
NCT04201418completed2022-05-24industrypast the reporting window
NCT04606563terminated— DSMC recommendation due to futility2022-04-22a university or hospitalpast the reporting window
NCT05328271completed2022-02-01a university or hospitalpast the reporting window
NCT04394117completed2021-11-14a university or hospitalpast the reporting window
NCT04753112completed2021-09-08a university or hospitalpast the reporting window
NCT03539809completed2021-08-15a university or hospitalpast the reporting window
NCT04330300suspended— Challenges with funding and very low incidence of COVID-19 at Irish study siteexpected 2021-07-31a university or hospital
NCT04859452completed2021-07-03industrypast the reporting window
NCT05857215completed2021-07-01industrypast the reporting window
NCT05361824completed2021-06-30a university or hospitalpast the reporting window
NCT04335786terminated— Enrollment was stopped to facilitate successful enrollment for the ACE2RAS-domain of the REMAP-CAP trial.2021-05-25a university or hospitalpast the reporting window
NCT04688294completed2021-05-01a university or hospitalpast the reporting window
NCT04785170completed2021-03-26industrypast the reporting window
NCT03893526completed2021-03-01a university or hospitalpast the reporting window
NCT04969536completed2021-02-23a university or hospitalpast the reporting window
NCT04467931completed2020-10-21a university or hospitalpast the reporting window
NCT05143398completed2020-10-15a university or hospitalpast the reporting window
NCT05096039completed2020-09-30industrypast the reporting window
NCT03168568completed2020-09-05a university or hospitalpast the reporting window
NCT02780219completed2020-03-06a university or hospitalpast the reporting window
NCT06801951completed2020-02-27a university or hospitalpast the reporting window
NCT04047940completed2020-02-18industrypast the reporting window
NCT02973035completed2020-01-06a university or hospitalpast the reporting window
NCT01912534completed2019-07a university or hospitalpast the reporting window
NCT03339232completed2019-06-17a university or hospitalpast the reporting window
NCT03990480completed2019-04-01a university or hospitalpast the reporting window
NCT01805804terminated— Recall of some valsartan preparations. 88 patients enrolled and completed the observation. All patients are in continuous observation and are well.2019-01-31a university or hospitalpast the reporting window
NCT04707508completed2019-01-23a university or hospitalpast the reporting window
NCT01638533completed2018-11-29NIHpast the reporting window
NCT01897012completed2018-10-31NIHpast the reporting window
NCT03371797completed2018-10-01industrypast the reporting window
NCT03532854completed2018-08-25industrypast the reporting window
NCT03745378completed2018-07-07a university or hospitalpast the reporting window
NCT00741585completed2018-06-30a university or hospitalpast the reporting window
NCT03639493completed2018-05-04industrypast the reporting window
NCT01590732completed2018-05-02a university or hospitalpast the reporting window
NCT02305056terminated2018-01-30a university or hospitalpast the reporting window
NCT03180593completed2018-01-25a university or hospitalpast the reporting window
NCT02687932completed2018-01-02a university or hospitalpast the reporting window
NCT02787798terminated— Today Entresto treatment has marketing authorization and is available for all patients, that is the reason why study was halted prematurely.2018-01a university or hospitalpast the reporting window
NCT03536598completed2017-09-04industrypast the reporting window
NCT02495324completed2017-05industrypast the reporting window
NCT02572960completed2017-05a university or hospitalpast the reporting window
NCT03017768completed2017-03-24a university or hospitalpast the reporting window
NCT03012763completed2017-01a university or hospitalpast the reporting window
NCT03657472completed2016-10-29industrypast the reporting window
NCT02631031completed2016-10a university or hospitalpast the reporting window
NCT00503152completed2016-07a university or hospitalpast the reporting window
NCT02145104completed2016-06-07industrypast the reporting window
NCT00494715completed2016-04a university or hospitalpast the reporting window
NCT02629874completed2015-07a university or hospitalpast the reporting window
NCT03393377completed2015-06a university or hospitalpast the reporting window
NCT02697305completed2015-05a university or hospitalpast the reporting window
NCT03009474completed2015-04industrypast the reporting window
NCT00140790terminated— The number of actual events was extremely low. We extended the study period, but it was still not enough. Also, many patients were loss of follow up.2015-03a university or hospitalpast the reporting window
NCT02343250completed2015-03industrypast the reporting window
NCT03784495completed2014-12-31a university or hospitalpast the reporting window
NCT01340326completed2014-12a university or hospitalpast the reporting window
NCT01819220completed2014-11a university or hospitalpast the reporting window
NCT00721773completed2014-10a university or hospitalpast the reporting window
NCT02110602completed2014-08a university or hospitalpast the reporting window
NCT02058823terminated— budget constraints2014-07-17a university or hospitalpast the reporting window
NCT02058446completed2014-03industrypast the reporting window
NCT01878201completed2014-02industrypast the reporting window
NCT02197442completed2014-02industrypast the reporting window
NCT02197494completed2014-02industrypast the reporting window
NCT03648333completed2014-02industrypast the reporting window
NCT02815657completed2014-01industrypast the reporting window
NCT03309618completed2013-11a university or hospitalpast the reporting window
NCT02518451completed2013-10industrypast the reporting window
NCT01609959completed2013-09a university or hospitalpast the reporting window
NCT01917149completed2013-07a university or hospitalpast the reporting window
NCT01819779completed2013-05industrypast the reporting window
NCT01928628completed2013-04industrypast the reporting window
NCT01764178completed2013-03-15industrypast the reporting window
NCT01672476completed2013-03industrypast the reporting window
NCT01350427completed2013-02a university or hospitalpast the reporting window
NCT00426348completed2013-01a university or hospitalpast the reporting window
NCT01415505completed2013-01industrypast the reporting window
NCT01541189completed2013-01industrypast the reporting window
NCT01918358completed2013-01industrypast the reporting window
NCT01767259completed2012-12a university or hospitalpast the reporting window
NCT01767298completed2012-12a university or hospitalpast the reporting window
NCT01735890completed2012-11industrypast the reporting window
NCT01776047completed2012-09industrypast the reporting window
NCT01652339completed2012-08industrypast the reporting window
NCT01402843completed2012-06industrypast the reporting window
NCT01004237completed2012-04a university or hospitalpast the reporting window
NCT01494727completed2012-04industrypast the reporting window
NCT01071122completed2012-02industrypast the reporting window
NCT01305018suspendedexpected 2012-01a university or hospital

Where it reaches

10 systems, 24 regions, 75 tissues, 146 transporter routes — routes, not measurements: transporters known to carry L-valine are expressed there, and no source reports it arriving.

Loading the model…

Nervous

Endocrine

Respiratory

Cardiovascular

Digestive

Urinary

Reproductive

Blood and immune

Musculoskeletal

Skin and adipose

Papers screened

781 papers

Compound: L-valine
Screened: 781
Admitted: 1
Discarded: 749
Not read: 31
Showing: 200 of 781

The whole record

Produced a finding1 paper

and 1 more.

Discarded: the wrong intervention687 papers

PMID:8913965cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:9109530cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:9427503cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:9822742cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:9878801cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:10368420cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:10372569cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:10436042cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:10465381cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:10487183cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:10627577cited by PMID:19837138; not about the subject it would be filed under2026-10-12
PMID:11453166cited by PMID:19837138; not about the subject it would be filed under2026-10-12

and 675 more.

Discarded: another reason, stated per paper32 papers

PMID:17572151no claim extracted — cause not determined — DOSED: occupational styrene exposure biomarker (styrene oxide adduct on N-terminal valine); L-valine not dosed2026-10-12
PMID:18425894no claim extracted — subject_absent — DOSED: aciclovir, ganciclovir, valaciclovir (valine ester prodrug of aciclovir), valganciclovir; L-valine itself never dosed | aciclovir, ganciclovir, valaciclovir, valganciclovir antivirals; L-valine itself not given, abstract2026-10-12
PMID:19167700no claim extracted — subject_absent — DOSED: BDNF Val66Met genotype; no valine compound administered or measured | BDNF Val66Met gene variant; no valine administered, abstract2026-10-12
PMID:22399073no claim extracted — subject_absent — DOSED: beta2-glycoprotein I Val/Leu247 polymorphism; no valine compound administered or measured | beta2-glycoprotein I Val/Leu247 polymorphism; no valine administered, abstract2026-10-12
PMID:23399523no claim extracted — subject_absent — DOSED: PRNP rs1799990 methionine/valine genotype; no valine compound administered or measured | PRNP M/V (methionine/valine) gene polymorphism rs1799990; no valine administered, abstract2026-10-12
PMID:25350717no claim extracted — cause not determined — DOSED: hemoglobin N-terminal valine adducts as exposure biomarkers; L-valine not dosed2026-10-12
PMID:27777201no claim extracted — subject_absent — DOSED: intradermal methylene blue; oral valaciclovir as background in both arms; L-valine never dosed | methylene blue plus lidocaine intradermally; oral valaciclovir given to both arms; L-valine not given, abstract2026-10-12
PMID:31234240no claim extracted — subject_absent — DOSED: valbenazine 40-80 mg/day (Methods); L-valine never named or dosed | valbenazine (VMAT2 inhibitor), 40-80 mg/day, Methods; L-valine not given2026-10-12
PMID:32569803no claim extracted — cause not determined — DOSED: glycidol exposure biomarker (N-substituted valine adduct in hemoglobin); L-valine not dosed2026-10-12
PMID:34652883no claim extracted — cause not determined — DOSED: furfuryl alcohol exposure biomarker (N-substituted valine adduct in hemoglobin); L-valine not dosed2026-10-12
PMID:37759723no claim extracted — cause not determined2026-10-12
PMID:19837138no claim extracted — subject_absent — DOSED: NMDA, spermidine, ifenprodil and APV in organotypic rat hippocampal slice cultures; L-valine is never mentioned | NMDA, spermidine, ifenprodil and APV in organotypic rat hippocampal slice cultures (Results); L-valine is never mentioned2026-10-11

and 20 more.

Discarded: not retrievable13 papers

PMID:6249441no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-12
PMID:8210177no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-12

and 11 more.

Discarded: an endpoint this vocabulary does not hold12 papers

PMID:11510866claims extracted but the object named resolved to no node — recorded in candidate_nodes (ADR-0070)2026-10-05
PMID:32222880no claim extracted — no_outcome_node — measured: myotube Akt phosphorylation ratio pAkt:Akt, western blot, in vitro | insulin signalling, pAkt:Akt ratio by western blot in C2C12 myotubes2026-10-05

and 10 more.

Discarded: no comparator3 papers

PMID:1437975no claim extracted — comparator_not_absence2026-10-05

and 2 more.

Discarded: no extractable result2 papers

and 2 more.

Not read yet31 papers

PMID:28928962026-10-12
PMID:175863032026-10-12
PMID:84350712026-10-08
PMID:152760212026-10-07
PMID:214713632026-10-04
PMID:215720902026-10-04
PMID:115481192026-09-29
PMID:126411822026-09-29
PMID:157304202026-09-29
PMID:161747232026-09-29
PMID:166862612026-09-29
PMID:93971062026-09-29

and 19 more.

Measured, not recorded

Compound: L-valine
Endpoints measured: 251 endpoints
Recorded as a finding: No

Show what was measured

extracellular 5-HIAA
no effect
Besides, L-valine does not prevent exercise-induced increase in 5-HIAA levels.
PMID:11510866 · one of two readings recorded this
extracellular 5-HIAA
increases
5-HIAA levels (from 90 min of exercise to 90 min of recovery)
PMID:11510866 · one of two readings recorded this
extracellular hippocampal 5-HT during and after treadmill running, in vivo microdialysis
decreases
Not recorded as a finding: no outcome node for extracellular 5-HT; read in the mechanism lane only as the tryptophan finding
Pre-exercise administration of L-valine prevents significantly the exercise-induced 5-HT release: 5-HT levels are maintained to baseline during exercise and recovery.
PMID:11510866 · one of two readings recorded this
extracellular tryptophan
decreases
we could observe a treatment-induced decrease in brain TRP levels (from 120 min of exercise to the end of recovery)
PMID:11510866 · one of two readings recorded this
extracellular tryptophan
increases
two hours of intensive running induced significant increases both in extracellular TRP levels (from 120 min of exercise to 30 min of recovery)
PMID:11510866 · one of two readings recorded this
hippocampal extracellular 5-HT release during and after treadmill exercise, in vivo microdialysis
decreases
Not recorded as a finding: no outcome node for hippocampal 5-HT; abstract only; sentence names L-valine but endpoint absent from outcome list
Pre-exercise administration of L-valine prevents significantly the exercise-induced 5-HT release: 5-HT levels are maintained to baseline during exercise and recovery.
PMID:11510866 · one of two readings recorded this
hippocampal extracellular 5-HT
decreases
Pre-exercise administration of L-valine prevents significantly the exercise-induced 5-HT release: 5-HT levels are maintained to baseline during exercise and recovery.
PMID:11510866 · one of two readings recorded this
hippocampal extracellular 5-HT
increases
in control group, hippocampal 5-HT levels increase from 123.7 +/- 6.4% at the end of exercise
PMID:11510866 · one of two readings recorded this
hippocampal extracellular 5-HT
increases
to 133.9 +/- 6.4% after 60 min of recovery
PMID:11510866 · one of two readings recorded this
bone ash and bone calcium
decreases, p = 0.05
Bone ash and bone calcium for Val-deficient birds were the lowest among the three groups studied (P < .05)
PMID:1437975 · one of two readings recorded this
fractional excretion of calcium
increases, p = 0.05
Fractional excretion of calcium in Val-deficient birds (.13%), however, was three times higher than that of Val-supplemented birds (P < .05)
PMID:1437975 · one of two readings recorded this
kidney function measurements
no effect
Kidney function measurements were the same for birds on the Val-supplemented and Val-deficient diets.
PMID:1437975 · one of two readings recorded this
plasma BCAA levels
modulates
The levels of the BCAA in plasma reflected those of the treatment diets.
PMID:1437975 · one of two readings recorded this
plasma hydroxyproline
decreases, p = 0.05
Plasma hydroxyproline was lowest in birds fed the Val-deficient diet (P < .05)
PMID:1437975 · one of two readings recorded this
weight gain, bone ash, bone calcium, plasma hydroxyproline and fractional calcium excretion in male broiler chicks
increases
Not recorded as a finding: the comparison was against another active treatment
In both studies birds fed the Val-supplemented gained more weight than birds in the other two groups.
PMID:1437975 · one of two readings recorded this
weight gain of male broiler chicks fed Val-deficient, BCAA-deficient or Val-supplemented diets, with bone ash, bone calcium and fractional calcium excretion
increases
Not recorded as a finding: the comparison was against another active treatment
In both studies birds fed the Val-supplemented gained more weight than birds in the other two groups.
PMID:1437975 · one of two readings recorded this
weight gain
no effect
Although birds on Val-deficient and BCAA-deficient diets had similar weight gain, the former were lethargic and showed feather and leg abnormalities.
PMID:1437975 · one of two readings recorded this
weight gain
increases
In both studies birds fed the Val-supplemented gained more weight than birds in the other two groups.
PMID:1437975 · one of two readings recorded this
SO-Hb adduct level, non-smokers versus smokers
unclear
a significant difference was found in levels of SO-Hb adducts between non-smokers and smokers among the control group
PMID:17572151 · one of two readings recorded this
Styrene oxide N-terminal valine hemoglobin adduct (SO-Hb) level
increases, p = 0.01
The levels of SO-Hb adducts were significantly higher (p<0.01) in the exposed subjects (5.98pmol/g globin) when compared with controls (2.59pmol/g globin)
PMID:17572151 · one of two readings recorded this
All-cause mortality
decreases
all-cause mortality (17 studies; RR 0.63, 95% CI 0.43 to 0.92)
PMID:18425894 · one of two readings recorded this
CMV disease, ganciclovir vs aciclovir in direct comparison
decreases
ganciclovir was more effective than aciclovir in preventing CMV disease (7 studies; RR 0.37, 95% CI 0.23 to 0.60)
PMID:18425894 · one of two readings recorded this
CMV disease
decreases
significantly reduced the risk for CMV disease (19 studies; RR 0.42, 95% CI 0.34 to 0.52)
PMID:18425894 · one of two readings recorded this
CMV infection
decreases
CMV infection (17 studies; RR 0.61, 95% CI 0.48 to 0.77)
PMID:18425894 · one of two readings recorded this
Mortality from CMV disease
decreases
reduced mortality from CMV disease (7 studies; RR 0.26, 95% CI 0.08 to 0.78)
PMID:18425894 · one of two readings recorded this
Prefrontal ventral and dorsal gyrification index change over 4 years
decreases, n = 36
Ventral and dorsal GI decreased significantly with time in both cohorts; the rate did not differ for bipolar patients
PMID:19167700 · one of two readings recorded this
Rate of gyrification index loss by BDNF Val66Met genotype within bipolar cohort
increases, n = 18
Within the bipolar cohort, individuals with one or more BDNF met alleles showed greater losses in GI, an effect that correlated with gray matter loss in the left hemisphere
PMID:19167700 · one of two readings recorded this
[125I]MK-801 binding, region main effect (CA1 vs CA3 or DG)
increases, p = 0.05
overall [125I]MK-801 binding was significantly greater in the CA1 region as compared to either the CA3 region or the DG (post hoc P < 0.05)
PMID:19837138 · one of two readings recorded this
[125I]MK-801 binding, spermidine effect within CA1
increases, p = 0.05
spermidine significantly elevated [125I]MK-801 binding only in the CA1 region (post hoc P < 0.05), showing a 26% increase in binding compared to cultures not exposed to spermidine
PMID:19837138 · one of two readings recorded this
[125I]MK-801 binding, spermidine treatment main effect (all hippocampus)
increases, p = 0.05
the presence of spermidine significantly elevated [125I]MK-801 binding in the hippocampus (post hoc P < 0.05)
PMID:19837138 · one of two readings recorded this
MAP-2 immunofluorescence by hippocampal region
modulates, p = 0.001
A one-way ANOVA indicated a significant difference in MAP-2 immunofluorescence among hippocampal regions (F(2, 23) = 22.095, P < 0.001
PMID:19837138 · one of two readings recorded this
NeuN immunofluorescence, CA3 versus DG
no effect, p = 0.079
No significant difference was detected in NeuN fluorescence between the CA3 region and DG (post hoc P = 0.079)
PMID:19837138 · one of two readings recorded this
NeuN immunofluorescence (mature neuron density) by hippocampal region
modulates, p = 0.001
A one-way ANOVA indicated a significant difference in NeuN immunofluorescence among hippocampal regions (F(2, 63) = 15.105, P < 0.001
PMID:19837138 · one of two readings recorded this
NeuN immunofluorescence (mature neuron density) by hippocampal region
Mean immunofluorescence (in optical units) in the CA1 region reached values of 41.85 ± 2.33, as compared to 25.50 ± 1.49 in the CA3 region and 30.78 ± 2.44 in the DG
PMID:19837138 · one of two readings recorded this
NR1 subunit immunoreactivity by hippocampal region
modulates, p = 0.001
NR1: F(2, 35) = 16.537, P < 0.001; NR2B: F(2, 35) = 21.985, P < 0.001
PMID:19837138 · one of two readings recorded this
NR1 subunit immunoreactivity by hippocampal region
Mean immunoreactivity for the NR1 subunit in the CA1 resulted in optical fluorescent values of 41.07 (± 3.56) and were nearly 50% greater than mean values for the CA3 region (21.73 ± 2.02) or the DG (26.74 ± 1.22)
PMID:19837138 · one of two readings recorded this
NR2B subunit immunoreactivity by hippocampal region
modulates, p = 0.001
NR1: F(2, 35) = 16.537, P < 0.001; NR2B: F(2, 35) = 21.985, P < 0.001
PMID:19837138 · one of two readings recorded this
NR2B subunit immunoreactivity by hippocampal region
mean values for the NR2B subunit were markedly elevated in the CA1 region (47.65 ± 3.63) compared to the CA3 region (24.50 ± 2.02) or the DG (28.50 ± 1.91)
PMID:19837138 · one of two readings recorded this
PI uptake, 10 μM NMDA in CA1 versus CA3 and DG
increases, p = 0.001
the toxicity observed in the CA1 region with exposure to 10 μM NMDA was greater than toxicity produced by 10 μM NMDA in either the CA3 region or DG (post hoc P < 0.001 for both comparisons)
PMID:19837138 · one of two readings recorded this
PI uptake after NMDA or ifenprodil in CA3 and DG
no effect
Toxicity was not observed after 24 hour exposure to any concentration of NMDA or ifenprodil in the CA3 region or DG
PMID:19837138 · one of two readings recorded this
PI uptake after spermidine in the absence of NMDA
no effect
Exposure to spermidine in the absence of NMDA did not produce toxicity in any hippocampal region
PMID:19837138 · one of two readings recorded this
PI uptake (neurotoxicity), 10 μM NMDA versus control in CA1
increases, p = 0.001
exposure to 10 μM NMDA produced significantly greater toxicity compared to control cultures (~350%; post hoc P < 0.001)
PMID:19837138 · one of two readings recorded this
PI uptake, NMDA plus APV versus NMDA alone in CA1
decreases, p = 0.001
the NMDAr antagonist APV significantly reduced toxicity produced by 10 μM NMDA (post hoc P < 0.001)
PMID:19837138 · one of two readings recorded this
PI uptake, NMDA plus ifenprodil versus NMDA alone in CA1
decreases, p = 0.001
toxicity was significantly reduced with co-exposure to the NR2B-specific polyamine-site antagonist ifenprodil (P < 0.001)
PMID:19837138 · one of two readings recorded this
PI uptake, NMDA plus spermidine versus NMDA alone in CA1
increases, p = 0.001
produced a marked increase in PI uptake in the CA1 pyramidal cell region, as compared to NMDA-treated cultures not exposed to spermidine (post hoc P < 0.001)
PMID:19837138 · one of two readings recorded this
PI uptake, NMDA plus spermidine versus NMDA plus spermidine plus ifenprodil in CA1
decreases, p = 0.01
This increase in PI uptake produced by co-exposure to NMDA and spermidine, to nearly 200% of control levels in the CA1 region, was significantly reduced by the addition of ifenprofil (post hoc P < 0.01)
PMID:19837138 · one of two readings recorded this
Diastolic blood pressure
no effect, p = 0.05
no interaction, condition, or time effects were noted for heart rate, systolic, or diastolic blood pressure (p > 0.05)
PMID:20885188 · one of two readings recorded this
Heart rate
no effect, p = 0.05
no interaction, condition, or time effects were noted for heart rate, systolic, or diastolic blood pressure (p > 0.05)
PMID:20885188 · one of two readings recorded this
Plasma nitrate/nitrite, condition effect
no effect, p = 0.18
No interaction (p = 0.99), condition (p = 0.18), or time (p = 0.98) effects were noted for plasma nitrate/nitrite
PMID:20885188 · one of two readings recorded this
Plasma nitrate/nitrite, interaction effect
no effect, p = 0.99
No interaction (p = 0.99), condition (p = 0.18), or time (p = 0.98) effects were noted for plasma nitrate/nitrite
PMID:20885188 · one of two readings recorded this
Plasma nitrate/nitrite, maximum increase
increases
values remaining nearly identical across time for placebo (∼27 μmol·L(-1)) and increasing a maximum of ∼6.7% (from 32.9 to 35.1 μmol·L(-1)) at the 15-minute collection period for the supplement
PMID:20885188 · one of two readings recorded this
Plasma nitrate/nitrite, placebo
no effect
values remaining nearly identical across time for placebo (∼27 μmol·L(-1)) and increasing a maximum of ∼6.7% (from 32.9 to 35.1 μmol·L(-1)) at the 15-minute collection period for the supplement
PMID:20885188 · one of two readings recorded this
Plasma nitrate/nitrite, time effect
no effect, p = 0.98
No interaction (p = 0.99), condition (p = 0.18), or time (p = 0.98) effects were noted for plasma nitrate/nitrite
PMID:20885188 · one of two readings recorded this
Systolic blood pressure
no effect, p = 0.05
no interaction, condition, or time effects were noted for heart rate, systolic, or diastolic blood pressure (p > 0.05)
PMID:20885188 · one of two readings recorded this
Anti-beta2GPI antibody positivity
increases, p = 0.042
OR 1.630, 95% CI 1.018-2.609, p = 0.042
PMID:22399073 · one of two readings recorded this
Susceptibility to anti-phospholipid syndrome
increases, p = 0.01
odds ratio (OR) 1.316, 95% confidence interval (CI) 1.068-1.621, p = 0.010
PMID:22399073 · one of two readings recorded this
Thrombosis-positive vs -negative patients, Val/Val + Val/Leu genotype
increases, p = 0.017
OR 2.817, 95% CI 1.200-6.610, p = 0.017
PMID:22399073 · one of two readings recorded this
Thrombosis-positive vs -negative patients, Val/Val vs Leu/Leu genotype
increases, p = 0.01
OR 3.312, 95% CI 1.338-8.200, p = 0.010
PMID:22399073 · one of two readings recorded this
Thrombosis
increases, p = 0.007
OR 1.908, 95% CI 1.195-3.046, p = 0.007
PMID:22399073 · one of two readings recorded this
Val allele frequency, anti-beta2GPI-positive vs -negative patients
increases, p = 0.041
OR 1.514, 95% CI 1.017-1.253, p = 0.041
PMID:22399073 · one of two readings recorded this
Miniature endplate current amplitude during interstimulus intervals
increases
High-frequency (10 Hz) motor nerve stimulation in a glycine-containing bathing solution also resulted in an increase in the amplitude of miniature endplate currents recorded during the interstimulus intervals
PMID:23121214 · one of two readings recorded this
Miniature endplate current amplitude
decreases
AChE inhibition by paraoxon, inactivation of NO synthase by N(x)-nitro-L-arginine methyl ester, and NMDA receptor blockade by DL-2-amino-5-phosphopentanoic acid prevented the increase in miniature endplate current amplitude caused by amino acids
PMID:23121214 · one of two readings recorded this
Nitric oxide production and partial AChE inhibition
increases
activation of N-methyl-d-aspartate (NMDA) receptors by combined application of glutamate and glycine led to enhancement of nitric oxide (NO) production, resulting in partial AChE inhibition
PMID:23121214 · one of two readings recorded this
Stimulation-induced increase in miniature endplate current amplitude
decreases
Pretreatment with an NO synthase inhibitor and NMDA receptor blockade fully eliminated this effect
PMID:23121214 · one of two readings recorded this
Alzheimer disease risk, PRNP V allele carriers vs MM
no effect, p = 0.57
but not in Asian V allele carriers (OR=1.11, 95% CI=0.78-1.57, P=0.57)
PMID:23399523 · one of two readings recorded this
Alzheimer disease risk, PRNP V allele carriers vs MM
decreases, p = 0.002
significant decreased risks of AD were found in the Caucasian V allele carriers (OR=0.85, 95% CI=0.77-0.94, P=0.002)
PMID:23399523 · one of two readings recorded this
Alzheimer disease risk, PRNP V allele carriers vs MM
no effect, p = 0.17
but not in early-onset Alzheimer disease (OR=0.86, 95% CI=0.70-1.06, P=0.17)
PMID:23399523 · one of two readings recorded this
Alzheimer disease risk, PRNP V allele carriers vs MM
decreases, p = 0.007
significant decreased risks of AD were associated with V allele carriers in late-onset Alzheimer disease (OR=0.76, 95% CI=0.62-0.93, P=0.007)
PMID:23399523 · one of two readings recorded this
Alzheimer disease risk, PRNP V allele carriers (VV+MV) vs MM
decreases, p = 0.004
The results indicated that the variant V allele carriers (VV+MV) had a 13% decreased risk of AD, when compared with the homozygote MM (VV+MV vs. MM: OR=0.87, 95% CI=0.79-0.96, P=0.004)
PMID:23399523 · one of two readings recorded this
Known N-terminal valine hemoglobin adducts identified
In all samples of smokers and nonsmokers, seven adducts were identified, of which six have previously been studied
PMID:25350717 · one of two readings recorded this
Precursor-ion scan mass range for valine adduct screening
covering a mass range of 135 Da (m/z 503-638)
PMID:25350717 · one of two readings recorded this
Unknown N-terminal valine adducts with fragmentation patterns similar to earlier studied valine adduct derivatives
Nineteen unknown adducts were observed, and 14 of those exhibited fragmentation patterns similar to earlier studied FTH derivatives of adducts to valine
PMID:25350717 · one of two readings recorded this
Hippocampal long-term potentiation in vivo
decreases
These behavioral effects were all obtained with a concentration of AP5 that, in a final study, was found to be sufficient to block hippocampal long-term potentiation (LTP) in vivo without affecting normal synaptic transmission
PMID:2552039 · one of two readings recorded this
Normal synaptic transmission in hippocampus
no effect
These behavioral effects were all obtained with a concentration of AP5 that, in a final study, was found to be sufficient to block hippocampal long-term potentiation (LTP) in vivo without affecting normal synaptic transmission
PMID:2552039 · one of two readings recorded this
Retention of previously acquired spatial information
no effect
Another experiment showed that AP5 did not affect the retention of previously acquired spatial information
PMID:2552039 · one of two readings recorded this
Sensorimotor function during learning
decreases
AP5 sometimes caused a disturbance of sensorimotor function during learning, but one experiment addressing whether this disturbance could be responsible for the spatial learning impairment established that it was statistically independent
PMID:2552039 · one of two readings recorded this
Spatial learning
decreases
The results show that chronic intraventricular infusion of the NMDA receptor antagonist D,L-2-amino-5-phosphonopentanoic acid (D,L-AP5) caused an impairment of spatial but not of visual discrimination learning in rats
PMID:2552039 · one of two readings recorded this
Visual discrimination learning
no effect
The results show that chronic intraventricular infusion of the NMDA receptor antagonist D,L-2-amino-5-phosphonopentanoic acid (D,L-AP5) caused an impairment of spatial but not of visual discrimination learning in rats
PMID:2552039 · one of two readings recorded this
Cancer cell death / apoptosis induction efficiency
increases
Evaluation of azapeptides 7-11 in MCF-7 breast cancer cells indicated aza-cyclohexanylglycyine analog 11 induced cell death more efficiently than the parent tetrapeptide likely by a caspase-9 mediated apoptotic pathway.
PMID:27087660 · one of two readings recorded this
cell death / apoptosis induction in MCF-7 breast cancer cells
increases
Evaluation of azapeptides 7-11 in MCF-7 breast cancer cells indicated aza-cyclohexanylglycyine analog 11 induced cell death more efficiently than the parent tetrapeptide likely by a caspase-9 mediated apoptotic pathway.
PMID:27087660 · one of two readings recorded this
Incidence of postherpetic neuralgia
decreases, p = 0.05
The incidence of postherpetic neuralgia was significantly lower in group A than in group B at 30 days (P<0.05)
PMID:27777201 · one of two readings recorded this
Incidence of postherpetic neuralgia
no effect
but not at 60 and 90 days after the treatment
PMID:27777201 · one of two readings recorded this
Incidence of postherpetic neuralgia
no effect
but not at 60 and 90 days after the treatment
PMID:27777201 · one of two readings recorded this
Time to no new blister formation, blister incrustation and decrustation, and pain relief
decreases, p = 0.05
the time for no new blister formation, blister incrustation and decrustation, and pain relief was significantly shortened in group A (P<0.05)
PMID:27777201 · one of two readings recorded this
Total clinical response rate
increases, p = 0.05
The total clinical response rate was 93.8% in group A, much higher than that in group B (62.5%, P<0.05)
PMID:27777201 · one of two readings recorded this
initial population spike amplitude
decreases
If added to slices already bathed in Mg2+ -free medium, the antagonist eliminated the multiple responses and partly reduced the amplitude of the initial population spike.
PMID:2859558 · one of two readings recorded this
multiple population spikes
decreases
An NMDA antagonist, which had no effect on the synaptic response in the presence of Mg2+, completely prevented the appearance of multiple responses.
PMID:2859558 · one of two readings recorded this
population spike amplitude and appearance of multiple population spikes
increases
Superfusion of slices with Mg2+ -free medium resulted in an increase in the amplitude of the population spike and the appearance of multiple population spikes.
PMID:2859558 · one of two readings recorded this
synaptic response in presence of Mg2+
no effect
An NMDA antagonist, which had no effect on the synaptic response in the presence of Mg2+, completely prevented the appearance of multiple responses.
PMID:2859558 · one of two readings recorded this
appetite perceptions (hunger, fullness, desire to eat, prospective food consumption) and GI symptoms (nausea, bloating)
no effect, n = 12
There were also no effects of treatment or time on ratings of these sensations and symptoms (p > 0.05 for all; A–F).
PMID:30621276 · one of two readings recorded this
blood glucose concentration
no effect, n = 12
There was no effect of treatment, or time, on blood glucose concentrations (p > 0.05; B).
PMID:30621276 · one of two readings recorded this
energy intake from an ad libitum buffet meal
no effect, n = 12
There was no effect of treatment on energy intake, or the amount eaten (gram; control: 1198 ± 94; L-Val-0.15: 1156 ± 83; L-Val-0.45: 1156 ± 97), from the buffet-meal (p > 0.05 for both).
PMID:30621276 · one of two readings recorded this
plasma cholecystokinin (CCK-8) concentration by radioimmunoassay during 90-min intraduodenal L-valine infusion
no effect
Not recorded as a finding: the supporting sentence never names the compound
There was no effect of treatment (p > 0.05), but an effect of time (p < 0.05), on plasma CCK concentrations A).
PMID:30621276 · one of two readings recorded this
plasma cholecystokinin (CCK-8) concentration
no effect, n = 12
There was no effect of treatment (p > 0.05), but an effect of time (p < 0.05), on plasma CCK concentrations A).
PMID:30621276 · one of two readings recorded this
Apoptosis induction
increases, (45.3% apoptosis for compound 6 vs 24.7% for TMZ in SNB19 cells)
SNB19 cells treated with 6 showed 45.3% apoptosis in the population, while TMZ had 24.7%.
PMID:30981767 · one of two readings recorded this
apoptosis proportion
increases, SNB19: 45.3% apoptosis with compound 6 vs 24.7% with TMZ
SNB19 cells treated with 6 showed 45.3% apoptosis in the population, while TMZ had 24.7%.
PMID:30981767 · one of two readings recorded this
Caspase 3/7 activation
increases
Both 6 and TMZ induced apoptosis through the activation of caspase 3/7 in SNB19 and LN229 cells.
PMID:30981767 · one of two readings recorded this
Cell cycle arrest (G2/M phase)
increases
Additionally, the treatment of both GBM cell lines with 6 led to G2/M phase arrest.
PMID:30981767 · one of two readings recorded this
cell cycle arrest (G2/M phase)
increases
Additionally, the treatment of both GBM cell lines with 6 led to G2/M phase arrest.
PMID:30981767 · one of two readings recorded this
cytotoxicity (growth inhibition, IC50) in glioblastoma cell lines
increases, IC50 of 49 μM and 53 μM for LN229 and SNB19 cells, respectively; higher than Temozolomide
Compound 6 was found to exhibit dose-dependent growth inhibitory effects with an IC50 of 49 μM and 53 μM for LN229 and SNB19 cells, respectively.
PMID:30981767 · one of two readings recorded this
Cytotoxicity / growth inhibition (IC50)
increases, (IC50 of 49 μM and 53 μM for LN229 and SNB19 cells, respectively)
Compound 6 was found to exhibit dose-dependent growth inhibitory effects with an IC50 of 49 μM and 53 μM for LN229 and SNB19 cells, respectively.
PMID:30981767 · one of two readings recorded this
reactive oxygen species production
increases
Boroxazolidone-treated GBM cell lines increased reactive oxygen species production, suggesting that such species may be interlinked with the observed programmed cell death.
PMID:30981767 · one of two readings recorded this
Reactive oxygen species (ROS) production
increases
Boroxazolidone-treated GBM cell lines increased reactive oxygen species production, suggesting that such species may be interlinked with the observed programmed cell death.
PMID:30981767 · one of two readings recorded this
exercise-induced fatigue on a 0-100 mm visual analog scale (VAS) and rating of perceived exertion (Borg 6-20 RPE) after 120 min cycling at 50% VO2max
decreases, 58.2 ± 16.5 vs. 62.6 ± 15.7, p = 0.010, p = 0.01, n = 39
Not recorded as a finding: the intervention held more than the compound
A subsequent Bonferroni-corrected post-hoc t-test demonstrated that the VAS score after the exercise was significantly lower in the AA group than that of the placebo group (58.2 ± 16.5 vs. 62.6 ± 15.7, p = 0.010), see Table 2.
PMID:30999554 · one of two readings recorded this
feeling of fatigue on a 0-100 visual analog scale (VAS) after 120 min cycling at 50% VO2max
decreases, 58.2 ± 16.5 vs. 62.6 ± 15.7, p = 0.010, p = 0.01, n = 39
A subsequent Bonferroni-corrected post-hoc t-test demonstrated that the VAS score after the exercise was significantly lower in the AA group than that of the placebo group (58.2 ± 16.5 vs. 62.6 ± 15.7, p = 0.010), see Table 2.
PMID:30999554 · one of two readings recorded this
physical parameters (blood pressure, pulse rate, body temperature, body weight, body fat percentage)
no effect, n = 39
A two-way repeated measures ANOVA (treatment × time) was conducted for the physical parameters and there were no significant predominant effects for treatment or interactions between treatment and time, see Table 6.
PMID:30999554 · one of two readings recorded this
rating of perceived exertion (Borg 6-20 RPE)
decreases, 7.7 ± 1.5 vs. 8.1 ± 1.5, p = 0.040, p = 0.04, n = 39
A post-hoc t-test showed that the RPE improved significantly in the AA group compared to that in the placebo group before the exercise (7.7 ± 1.5 vs. 8.1 ± 1.5, p = 0.040), see Table 3.
PMID:30999554 · one of two readings recorded this
serum total ketone body increase during exercise
decreases, p = 0.034, n = 39
There was a significant interaction between treatment and time on serum total ketone bodies (p = 0.034).
PMID:30999554 · one of two readings recorded this
Age, mean (SD), baseline characteristic
Age, mean (SD), years | 55.8 (10.1) | 54.9 (9.1) | 56.2 (10.4)
PMID:31234240 · one of two readings recorded this
AIMS MCID estimate, CGI-TD score <=2 at week 6
the estimated MCID for AIMS total score was 3 points
PMID:31234240 · one of two readings recorded this
AIMS MCID estimate, CGI-TD score <=3 at week 6
the estimated MCID for AIMS total score was 2 points
PMID:31234240 · one of two readings recorded this
AIMS MCID estimate, PGIC score <=2
Analyses based on PGIC score ≤2 also yielded an MCID estimation of 2 points
PMID:31234240 · one of two readings recorded this
AIMS MCID estimate, PGIC score <=3
analyses based on PGIC score ≤3 yielded an MCID estimation of 2 points, with a median 20% improvement from baseline
PMID:31234240 · one of two readings recorded this
AIMS mean percent improvement, CGI-TD score <=2 at week 6
increases
corresponding to a percent improvement of 31.0% (±5.3%)
PMID:31234240 · one of two readings recorded this
AIMS mean percent improvement, CGI-TD score <=3 at week 6
increases
These changes corresponded to a mean percent improvement of 17.2% (±3.5%)
PMID:31234240 · one of two readings recorded this
AIMS total score at baseline, mean (SD)
Mean (SD) | 8.9 (4.4) | 9.0 (4.2) | 9.5 (3.6)
PMID:31234240 · one of two readings recorded this
AIMS total score change from baseline, CGI-TD score <=2 at week 6
decreases
The mean change from baseline in AIMS total score was –3.4 (±0.4), corresponding to a percent improvement of 31.0% (±5.3%)
PMID:31234240 · one of two readings recorded this
AIMS total score change from baseline, CGI-TD score <=3 at week 6
decreases
The mean change from baseline (± standard error of the mean [SEM]) in AIMS total score was –2.2 (±0.2) and the median change was –2 (range, –13 to 8)
PMID:31234240 · one of two readings recorded this
AIMS total score, LS mean difference from placebo, change from baseline
decreases
Least squares mean differences from placebo were –1.7 and –2.6
PMID:31234240 · one of two readings recorded this
AIMS total score, LS mean difference from placebo, change from baseline
decreases
Least squares mean differences from placebo were –1.7 and –2.6
PMID:31234240 · one of two readings recorded this
AIMS total score median change from baseline, CGI-TD score <=2 at week 6
decreases
The median score change was –3 (range, –13 to 8)
PMID:31234240 · one of two readings recorded this
BPRS score at screening, mean (SD)
BPRS score at screening, mean (SD) | 30.5 (7.6) | 31.6 (7.9) | 28.9 (6.8)
PMID:31234240 · one of two readings recorded this
heart rate
increases, increase of 28 (3.7) beats/min, n = 6
This was accompanied by flushing, a significant increase in heart rate of 28 (3.7) beats/min and skin temperature of 1.8 degrees (0.16 degrees) C, but no effect on systolic or diastolic blood pressure.
PMID:3206383 · one of two readings recorded this
systolic and diastolic blood pressure
no effect, n = 6
This was accompanied by flushing, a significant increase in heart rate of 28 (3.7) beats/min and skin temperature of 1.8 degrees (0.16 degrees) C, but no effect on systolic or diastolic blood pressure.
PMID:3206383 · one of two readings recorded this
Bckdha mRNA expression
decreases
valine reduced branched-chain alpha-keto acid dehydrogenase a (Bckdha) mRNA (but not protein) expression which was exacerbated by insulin resistance
PMID:32222880 · one of two readings recorded this
Bckdha protein expression
no effect
valine reduced branched-chain alpha-keto acid dehydrogenase a (Bckdha) mRNA (but not protein) expression which was exacerbated by insulin resistance
PMID:32222880 · one of two readings recorded this
insulin sensitivity indicated by pAkt:Akt (western blot) in C2C12 myotubes treated with valine
no effect
Not recorded as a finding: this platform holds no node for the endpoint
Valine treatment had no effect on pAkt:Akt following either acute or 48-h treatment, regardless of insulin stimulation or varying levels of insulin resistance.
PMID:32222880 · one of two readings recorded this
insulin sensitivity (pAkt:Akt)
no effect
Valine treatment had no effect on pAkt:Akt following either acute or 48-h treatment, regardless of insulin stimulation or varying levels of insulin resistance.
PMID:32222880 · one of two readings recorded this
myotube insulin sensitivity, pAkt:Akt ratio by western blot, C2C12 cells
no effect
Not recorded as a finding: this platform holds no node for the endpoint
Valine treatment had no effect on pAkt:Akt following either acute or 48-h treatment, regardless of insulin stimulation or varying levels of insulin resistance.
PMID:32222880 · one of two readings recorded this
regulators of mitochondrial biogenesis or glycolysis
no effect
Valine did not alter regulators of mitochondrial biogenesis or glycolysis
PMID:32222880 · one of two readings recorded this
2,3-diHOPr-Val adduct level (median)
with medians of 5.4 (range: 2.3-29.2) and 1.6 (range: LOD - 8.9) pmol/g hemoglobin)
PMID:32569803 · one of two readings recorded this
2,3-diHOPr-Val adduct level (median)
n = 100
with medians of 5.4 (range: 2.3-29.2) and 1.6 (range: LOD - 8.9) pmol/g hemoglobin)
PMID:32569803 · one of two readings recorded this
2,3-diHOPr-Val adduct level (median)
n = 6
the median 2,3-diHOPr-Val levels were 16.7 (range: 6.4-29.2) and 6.2 (range: LOD - 8.6) pmol/g hemoglobin
PMID:32569803 · one of two readings recorded this
2,3-diHOPr-Val adduct level (median)
n = 6
the median 2,3-diHOPr-Val levels were 16.7 (range: 6.4-29.2) and 6.2 (range: LOD - 8.6) pmol/g hemoglobin
PMID:32569803 · one of two readings recorded this
Detection of 2,3-diHOPr-Val hemoglobin adduct
n = 100
2,3-DiHOPr-Val was detectable in all 100 maternal blood samples and in 96 cord blood samples (LOD =0.5 pmol 2,3-diHOPr-Val/g hemoglobin)
PMID:32569803 · one of two readings recorded this
Ratio of cord to maternal blood 2,3-diHOPr-Val level (median)
n = 49
The median ratio of 2,3-diHOPr-Val levels of cord to maternal blood was 0.35 (range: 0.19-1.14) (n = 49)
PMID:32569803 · one of two readings recorded this
Spearman correlation of 2,3-diHOPr-Val between cord and maternal blood
increases, p = 0.001
The Spearman correlation coefficient between 2,3-diHOPr-Val levels in cord and maternal blood samples was 0.63 (p < 0.001) among all mother-newborn pairs
PMID:32569803 · one of two readings recorded this
Spearman correlation of 2,3-diHOPr-Val between cord and maternal blood
increases, p = 0.001
0.59 (p < 0.001) among mother-newborn pairs of non-smoking mothers
PMID:32569803 · one of two readings recorded this
body weight change after sham surgery
no effect
In marked contrast, sham-operated DIO mice re-gained their pre-operative weight by post-operative day 14 (−5%)
PMID:34155969 · one of two readings recorded this
body weight change after sleeve gastrectomy
decreases
Subsequent to SGx, we observed a significant weight loss (−34% by 2 weeks)
PMID:34155969 · one of two readings recorded this
body weight with MCHR1-I alone
decreases
Treatment with MCHR1-I in DIO-obese mice led to decreased food intake and subsequent weight loss.
PMID:34155969 · one of two readings recorded this
body weight with TDCA/valine and intracerebral recombinant MCH
increases
Strikingly, this effect was significantly diminished when co-administering recombinant MCH and TDCA/valine, suggesting an inhibitory effect of TDCA/valine on MCH regulation.
PMID:34155969 · one of two readings recorded this
body weight
decreases
resulting in robust weight loss that went beyond the observed effects in mice undergoing SGx
PMID:34155969 · one of two readings recorded this
body weight
no effect
Importantly, administration of TDCA/valine to lean control mice did not impact weight loss.
PMID:34155969 · one of two readings recorded this
body weight
decreases, n = 5
Of note, isolated administration of either TDCA or valine was found to be less effective as assessed by body weight measurements over a course of 30 days with daily, i.p. TDCA or valine injections.
PMID:34155969 · one of two readings recorded this
cumulative energy intake and hourly food intake
decreases, n = 6
While cumulative energy intake and the hourly food intake significantly declined in TDCA/valine-treated animals compared to PBS-treated controls
PMID:34155969 · one of two readings recorded this
energy expenditure and total activity
no effect, n = 6
hourly measured energy expenditure and the measured total activity did not change during treatment
PMID:34155969 · one of two readings recorded this
food intake and body weight with MCHR1-I plus TDCA/valine
no effect
simultaneous treatment with both MCHR1-I and TDCA/valine did not further reduce food intake or promote additional weight loss in DIO mice
PMID:34155969 · one of two readings recorded this
glucose tolerance (insulin resistance)
decreases
DIO mice treated with TDCA/valine displayed a complete reversal of obesity-related insulin resistance comparable to lean controls.
PMID:34155969 · one of two readings recorded this
hypothalamic MCH mRNA increase with fasting
decreases
Our analysis revealed a substantial attenuation in the increase of MCH with fasting following TDCA/valine treatment.
PMID:34155969 · one of two readings recorded this
number of metabolites detected and significantly different between lean and DIO mice
unclear
Our unbiased approach detected 260 metabolites with 17 candidates showing a significant statistical difference between lean and DIO mice by analysis of variance (ANOVA), heat mapping, and SAM
PMID:34155969 · one of two readings recorded this
plasma valine concentration after TDCA/valine injection
increases, n = 5
Notably, the combined injection of TDCA and valine increased absolute, systemic TDCA and valine concentrations in DIO mice comparable to levels measured in lean control mice
PMID:34155969 · one of two readings recorded this
respiratory exchange ratio and energy balance
decreases, n = 6
Moreover, the respiratory exchange ratio and energy balance of TDCA/valine-treated obese animals significantly declined, supporting the significance of fatty acids for energy metabolism.
PMID:34155969 · one of two readings recorded this
serum valine level after sleeve gastrectomy
increases, n = 6
Subsequent to clinical SGx, we observed a significant increase in both TDCA and valine levels, indicating a similar impact of SGx in mice and humans.
PMID:34155969 · one of two readings recorded this
subcutaneous and epididymal fat stores
decreases
we assessed subcutaneous and epididymal adipose tissue stores and found a significant decrease of both fat stores in TDCA/valine-treated DIO mice comparable to effects observed in DIO mice that underwent SGx
PMID:34155969 · one of two readings recorded this
systemic L-valine level after sleeve gastrectomy
increases
Obese animals, that underwent SGx, however, displayed overall restored levels of both metabolites, suggesting a critical involvement of TDCA/valine in the metabolic underpinning of SGx-induced weight loss.
PMID:34155969 · one of two readings recorded this
systemic L-valine level
decreases
We found significantly decreased systemic levels of TDCA and L-valine in DIO mice.
PMID:34155969 · one of two readings recorded this
systemic leptin level
decreases
Indeed, our results indicated reduced systemic leptin levels in both, SGx and TDCA/valine-treated animals.
PMID:34155969 · one of two readings recorded this
allogeneic skin graft survival and splenic CD4+/CD8+ T cell IFN-γ, IL-10 and IL-17 production in diet-induced obese mice
increases
Not recorded as a finding: the intervention held more than the compound
Notably, the combinatorial treatment with TDCA and valine resulted in a more prominent prolongation of graft survival comparable to that in DIO mice that underwent SGx.
PMID:34551205 · one of two readings recorded this
allogeneic skin graft survival
increases
Notably, the combinatorial treatment with TDCA and valine resulted in a more prominent prolongation of graft survival comparable to that in DIO mice that underwent SGx.
PMID:34551205 · one of two readings recorded this
allograft survival duration in diet-induced obese mice treated with taurodeoxycholic acid (TDCA) and valine
increases
Not recorded as a finding: the intervention held more than the compound
Administering taurodeoxycholic acid (TDCA) and valine, metabolites depleted in DIO-mice and restored through SGx, prolonged graft survival in DIO-mice comparable with SGx an dampened Th1 and Th17 alloimmune responses while Treg frequencies and CD4+ T cell-derived IL-10 production were augmented.
PMID:34551205 · one of two readings recorded this
allograft survival in diet-induced obese mice treated with taurodeoxycholic acid (TDCA) plus valine
increases, prolonged graft survival, comparable with sleeve gastrectomy (SGx)
Not recorded as a finding: the intervention held more than the compound
Administering taurodeoxycholic acid (TDCA) and valine, metabolites depleted in DIO-mice and restored through SGx, prolonged graft survival in DIO-mice comparable with SGx an dampened Th1 and Th17 alloimmune responses while Treg frequencies and CD4+ T cell-derived IL-10 production were augmented.
PMID:34551205 · one of two readings recorded this
donor-specific antibody levels
decreases
Notably, DSA levels had been comparable in lean and DIO control mice while TDCA/valine treatment caused a significant reduction indicating immunosuppressive effects of TDCA/valine on the indirect immune response.
PMID:34551205 · one of two readings recorded this
M1 macrophage (F4/80+CD11b+CD11c+) frequency
decreases
Treatment with TDCA/valine resulted in a significant systemic reduction of splenic M1-like CD11b+CD11c+ cells, a cell population known to promote Th1 T cell differentiation in obesity.
PMID:34551205 · one of two readings recorded this
splenic CD4+/CD8+ T cell IFN-γ production
decreases
Notably, prior to graft rejection, DIO mice exhibited significantly increased IFN-γ production by both splenic CD4+ and CD8+ T cells.
PMID:34551205 · one of two readings recorded this
Hemoglobin adduct FFA-Val level
increases, p = 0.001
In the birth cohort, FFA-Val levels are distinctly higher in maternal compared to newborn samples (median 15.2 vs 2.2 pmol g-1 hemoglobin, p < 0.001)
PMID:34652883 · one of two readings recorded this
Hemoglobin adduct FFA-Val level
decreases, p = 0.003
and lower in non-smokers compared to smokers (median 14.1 vs 17.0 pmol g-1 hemoglobin, p = 0.003)
PMID:34652883 · one of two readings recorded this
Hemoglobin adduct FFA-Val level
decreases, p = 0.008
In the RBVD study, FFA-Val levels are lower in vegans compared to omnivores (median 13.0 vs 15.8 pmol g-1 hemoglobin, p = 0.008)
PMID:34652883 · one of two readings recorded this
leukaemic burden and survival in T-ALL-bearing mice under dietary valine restriction versus normal diet
increases
Not recorded as a finding: the comparison was against another active treatment
Limiting valine bioavailability through restriction of dietary valine intake disrupted this balance in mice, resulting in decreased leukaemic burden and increased survival in vivo.
PMID:34937946 · one of two readings recorded this
survival and leukaemic burden in T-ALL-bearing mice given a dietary valine-restricted diet vs a normal diet
increases, increased survival together with decreased leukaemic burden in vivo
Not recorded as a finding: the comparison was against another active treatment
Limiting valine bioavailability through restriction of dietary valine intake disrupted this balance in mice, resulting in decreased leukaemic burden and increased survival in vivo.
PMID:34937946 · one of two readings recorded this
Movement disorder occurrence and phenotype spectrum
(Permanent or paroxysmal MDs recorded in 61% of HIBCHD patients and 72% of ECHS1D patients), n = 123
Permanent or paroxysmal MDs were recorded in 61% of HIBCHD patients and 72% of ECHS1D patients.
PMID:36200804 · one of two readings recorded this
movement disorder phenotype (dystonia, chorea, parkinsonism, athetosis, myoclonus, tremor, abnormal eye movements) in HIBCH/ECHS1 deficiency
Permanent or paroxysmal MDs were recorded in 61% of HIBCHD patients and 72% of ECHS1D patients., n = 123
Permanent or paroxysmal MDs were recorded in 61% of HIBCHD patients and 72% of ECHS1D patients.
PMID:36200804 · one of two readings recorded this
environmental L-valine import flux and reaction essentiality in context-specific models
increases, mean net import flux = 8.959
When quantified, there was consistently a large positive net import flux across valine-associated reactions in clinical isolate models (mean net import flux = 8.959) (Supplementary Table 4).
PMID:36307414 · one of two readings recorded this
cortical bone area and trabecular thickness at the distal tibia by HR-pQCT
increases, n = 449
Circulating valine was associated with specific bone microstructure features with the most pronounced associations observed for cortical cross-sectional bone area and trabecular bone thickness (Table 2).
PMID:37178220 · one of two readings recorded this
hip fracture incidence, Cox proportional hazards (UK Biobank) / logistic regression (UFO) hazard or odds ratio per SD increase in circulating valine, ICD-code and hospital-record ascertained
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Valine levels were inversely associated with hip fractures in the UFO study also.
PMID:37178220 · one of two readings recorded this
incident hip fracture, meta-analysis (UK Biobank + UFO) odds ratio per SD increase in circulating valine
decreases, OR per SD increase 0.84, 95% CI 0.80-0.88, p = 2.3e-14, n = 3126
Meta-analyses of data from the UK Biobank and UFO studies (3126 hip fracture cases) provided statistical evidence that circulating valine is a predictor of hip fracture risk (OR per SD increase, 0.84, 95% CI 0.80-0.88, P = 2.3 × 10−14,.
PMID:37178220 · one of two readings recorded this
1-year all-cause mortality by endogenous serum valine level at admission (NMR spectroscopy) in acute heart failure
hazard ratio 0.73 per 1 standard deviation increase, 95% confidence interval: 0.59-0.90, p = 0.003
Not recorded as a finding: the direction is carried only as a signed number
Of these, only valine was significantly associated with 1-year mortality (hazard ratio 0.73 per 1 standard deviation increase, 95% confidence interval: 0.59-0.90, p = 0.003) in the multivariable Cox regression analyses.
PMID:37759723 · one of two readings recorded this
1-year all-cause mortality (deaths among AHF patients)
n = 315
Out of 315 AHF patients, 118 (37.5%) died within 1 year after hospitalization for AHF
PMID:37759723 · one of two readings recorded this
1-year mortality association with serum valine (multivariable Cox regression)
decreases, p = 0.003
Of these, only valine was significantly associated with 1-year mortality (hazard ratio 0.73 per 1 standard deviation increase, 95% confidence interval: 0.59-0.90, p = 0.003) in the multivariable Cox regression analyses
PMID:37759723 · one of two readings recorded this
Discrimination of 1-year survivors versus non-survivors by serum valine (ROC AUC)
In a receiver operating characteristics curve analysis, valine was able to discriminate between the two groups with an area under the curve of 0.65 (95% CI 0.59-0.72)
PMID:37759723 · one of two readings recorded this
Survival (Kaplan-Meier) by serum valine above versus at or below the median
increases
Kaplan-Maier analysis showed significantly higher survival rates in AHF patients with valine levels above the median (>279.2 µmol/L) compared to those with valine levels ≤ 279.2 µmol/L
PMID:37759723 · one of two readings recorded this
autophagy-related gene expression (Atg5, Lamb3)
decreases
Moreover, gene expression levels related to autophagy (Atg5 and Lamb3), DNA 5 mC methylation (Dnmt1, Dnmt3a, Tet2 and Tet3), RNA m6A methylation (Mettl14, Alkbh5 and Fto), and m6A methylation binding proteins (Ythdf1/2/3 and Igf2bp1/2) were significantly reduced.
PMID:38000127 · one of two readings recorded this
Body and testis weight
no effect
l-valine supplementation (0.30% or 0.45%, water drinking for 3 weeks) did not change body and testis weights, but significantly altered morphology of sertoli cells and germ cells within seminiferous tubule, and enlarged the space between seminiferous tubules within mouse testis.
PMID:38000127 · one of two readings recorded this
protein abundance (ALKBH5, FTO, YTHDF3)
decreases
Protein abundances of ALKBH5, FTO and YTHDF3 were also significantly reduced, but not for ATG5 and TET2.
PMID:38000127 · one of two readings recorded this
testicular apoptosis (Caspase3/9 mRNA, CASPASE9 protein)
increases
l-valine treatment (0.45%) increased significantly the Caspase3/9 mRNA levels and CASPASE9 protein levels, therefore induced apoptosis of mouse testis.
PMID:38000127 · one of two readings recorded this
Testis apoptosis (Caspase3/9 mRNA, CASPASE9 protein)
increases
l-valine treatment (0.45%) increased significantly the Caspase3/9 mRNA levels and CASPASE9 protein levels, therefore induced apoptosis of mouse testis.
PMID:38000127 · one of two readings recorded this
testis apoptosis marker levels (Caspase3/9 mRNA and CASPASE9 protein) after l-valine water supplementation in mice
increases
Not recorded as a finding: this platform holds no node for the endpoint
l-valine treatment (0.45%) increased significantly the Caspase3/9 mRNA levels and CASPASE9 protein levels, therefore induced apoptosis of mouse testis.
PMID:38000127 · one of two readings recorded this
Testis gene expression (autophagy, DNA methylation, RNA m6A methylation genes)
decreases
Moreover, gene expression levels related to autophagy (Atg5 and Lamb3), DNA 5 mC methylation (Dnmt1, Dnmt3a, Tet2 and Tet3), RNA m6A methylation (Mettl14, Alkbh5 and Fto), and m6A methylation binding proteins (Ythdf1/2/3 and Igf2bp1/2) were significantly reduced.
PMID:38000127 · one of two readings recorded this
Testis protein abundance (ALKBH5, FTO, YTHDF3, ATG5, TET2)
decreases
Protein abundances of ALKBH5, FTO and YTHDF3 were also significantly reduced, but not for ATG5 and TET2.
PMID:38000127 · one of two readings recorded this
Testis transcriptome differentially expressed genes
decreases, (DEGs, 26 up-regulated and 511 down-regulated)
Testis transcriptome sequencing detected 537 differentially expressed genes (DEGs, 26 up-regulated and 511 down-regulated), involved in multiple important signaling pathways.
PMID:38000127 · one of two readings recorded this
ATP and NAD/NADH production rate
increases
The treatment of valine at 1.0 m m concentration for 24 h, resulted in significantly higher ATP and NAD/NADH production rates (Figure S2a and b).
PMID:38093456 · one of two readings recorded this
ATP generation rate and oxidative phosphorylation under oxidative stress, XFe96 analyzer
increases
Not recorded as a finding: ATP generation rate and oxidative phosphorylation are pathway-level readouts, not a named protein/enzyme target, so no mechanism predicate applies
Valine sustained oxidative phosphorylation and improved ATP generation rates during oxidative stress.
PMID:38093456 · one of two readings recorded this
electron transport chain complex I, II and IV respiration
increases
The respiration rates of complexes I (NADH/ubiquinone oxidoreductase), II (succinate dehydrogenase), and IV (cytochrome c oxidase) increased after treatment.
PMID:38093456 · one of two readings recorded this
mitochondrial complex I, II and IV electron transport chain function, mitochondrial ROS, 4-hydroxynonenal, and oxidative phosphorylation/ATP generation rate in valine-treated cells in vitro
increases
Not recorded as a finding: another reason, stated per paper
Valine sustained oxidative phosphorylation and improved ATP generation rates during oxidative stress.
PMID:38093456 · one of two readings recorded this
mitochondrial oxygen consumption rate (basal, maximal, spare respiratory capacity)
increases
Valine treatment resulted in increased OCR production and, therefore improved the mitochondrial function in C2C12 cells.
PMID:38093456 · one of two readings recorded this
mitochondrial oxygen consumption rate (OCR), ATP production rate and mitochondrial ROS (MitoSOX) in C2C12 myoblasts following valine treatment, Seahorse extracellular flux analysis and flow cytometry
increases
Not recorded as a finding: this platform holds no node for the endpoint
Valine treatment resulted in increased OCR production and, therefore improved the mitochondrial function in C2C12 cells.
PMID:38093456 · one of two readings recorded this
mitochondrial reactive oxygen species and 4-hydroxynonenal protein expression under oxidative stress, flow cytometry
decreases
Not recorded as a finding: reactive oxygen species and 4-hydroxynonenal are not a protein/enzyme target and expression is not an activity measure, so no mechanism predicate applies
Flow cytometry studies revealed, valine reduced oxidative stress by significantly lowering mitochondrial reactive oxygen species and protein expression of 4-hydroxynonenal.
PMID:38093456 · one of two readings recorded this
mitochondrial reactive oxygen species (MitoSOX) after H2O2 challenge
decreases, 55.6% of cells ROS positive with H2O2 alone vs. 28.8% with H2O2 plus valine
ROS generation was evaluated using a flow cytometer. H2O2 treatment caused ROS production in 55.6% of cells, whereas, when H2O2 was used along with valine, recovery from oxidative stress was improved and only 28.8% of cells were ROS positive.
PMID:38093456 · one of two readings recorded this
Anti-Bacillus cereus antibacterial activity
increases
Heterologous expression of the sla gene cluster led to the discovery of a new compound, slamysin (1), characterized by an N-acylated amino acid structure and demonstrating weak anti-Bacillus cereus activity.
PMID:38447096 · one of two readings recorded this
antibacterial activity against Bacillus cereus
increases, weak anti-Bacillus cereus activity
Heterologous expression of the sla gene cluster led to the discovery of a new compound, slamysin (1), characterized by an N-acylated amino acid structure and demonstrating weak anti-Bacillus cereus activity.
PMID:38447096 · one of two readings recorded this

The whole record — 251 rows

Sources cited

1 paper

Subject: L-valine
Findings: 1
Papers: 1

Human HDAC6 senses valine abundancy to regulate DNA damage.record2025PMID:395676881 finding

Other names

7 names

Resolves to: L-valine

Also called: (2S)-2-amino-3-methylbutanoic acid(S)-valine2-Amino-3-methylbutyric acidL-(+)-alpha-Aminoisovaleric acidL-alpha-Amino-beta-methylbutyric acidValVALINE